Processing 00000000.tx.1: Increased Insulin Translation from an Insulin Splice-Variant Overexpressed in Diabetes, Obesity, and Insulin Resistance Alexandra H. 

Phrase: "Increased Insulin Translation from an Insulin Splice-Variant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0040712:Translation [Intellectual Product]
   744   C0597295:translation [Molecular Function]
   744   C1519614:Translation [Genetic Function]

Phrase: "Overexpressed in Diabetes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   756   C1514559:overexpress [Genetic Function]

Phrase: "Obesity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "and"

Phrase: "Insulin Resistance Alexandra H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0033727:H+ [Element, Ion, or Isotope]
   812   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441932:H+ [Classification]
   812   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.2: Minn, Hong Lan, Mary E. 

Phrase: "Minn,"

Phrase: "Hong Lan,"

Phrase: "Mary E."
Processing 00000000.tx.3: Rabaglia, David M. 

Phrase: "Rabaglia,"

Phrase: "David M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.4: Harlan, Brenda A. 

Phrase: "Harlan,"

Phrase: "Brenda A."
Processing 00000000.tx.5: Peculis, Alan D. 

Phrase: "Peculis,"

Phrase: "Alan D."
Processing 00000000.tx.6: Attie and Anath Shalev Department of Medicine, University of Wisconsin (A.H.M., A.S.), Madison, Wisconsin 53792; 

Phrase: "Attie"

Phrase: "and"

Phrase: "Anath Shalev Department of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "University of Wisconsin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0041740:University [Manufactured Object,Organization]
   827   C0043193:Wisconsin [Geographic Area]

Phrase: "(A.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "A.S."

Phrase: ")"

Phrase: ","

Phrase: "Madison,"

Phrase: "Wisconsin 53792"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043193:Wisconsin [Geographic Area]

Phrase: ";"
Processing 00000000.tx.7: Department of Biochemistry, University of Wisconsin (H.L., M.E.R., A.D.A.), Madison, Wisconsin 53706; 

Phrase: "Department of Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "University of Wisconsin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0041740:University [Manufactured Object,Organization]
   827   C0043193:Wisconsin [Geographic Area]

Phrase: "(H.L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346686:h l [Quantitative Concept]

Phrase: "M."

Phrase: "E.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "A.D.A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: ")"

Phrase: ","

Phrase: "Madison,"

Phrase: "Wisconsin 53706"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043193:Wisconsin [Geographic Area]

Phrase: ";"
Processing 00000000.tx.8: and National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services (D.M.H., B.A.P.), Bethesda, Maryland 20892 Address requests for reprints to: Dr. 

Phrase: "and"

Phrase: "National Institute of Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "and"

Phrase: "Digestive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012238:Digestive [Organism Function]
  1000   C0012240:Digestive [Body System]

Phrase: "and"

Phrase: "Kidney Diseases,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0022658:Kidney Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   861   C0022646:Kidney [Body Part, Organ, or Organ Component]
   861   C0227665:kidney [Body Part, Organ, or Organ Component]
   861   C1278978:Kidney [Body Part, Organ, or Organ Component]
   861   C1514845:KIDNEY [Tissue]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]
   768 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "National Institutes of Health,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "Department of Health and Human Services"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0041711:Department of Health and Human Services [Health Care Related Organization]
           department health human services
   858   C0018747:Health Services [Health Care Activity]
   827   C0037440:human services [Self-help or Relief Organization]
   799   C0018684:Health [Idea or Concept]
   799   C0086418:Human [Human]
   799   C0557854:Services [Occupational Activity]
   799   C1704729:Department [Organization]
   766 E C2825316:Service [Manufactured Object]
   766 E C3245478:service [Idea or Concept]

Phrase: "("

Phrase: "D."

Phrase: "M."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "B.A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "Bethesda,"

Phrase: "Maryland 20892 Address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0376649:Address [Intellectual Product]
   827   C1442065:Address [Spatial Concept]

Phrase: "requests for reprints"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C0686900:Request for [Functional Concept]
           request
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
   756   C3273171:Reprint [Intellectual Product]

Phrase: "to"

Phrase: ":"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.9: Anath Shalev, University of Wisconsin-Madison, H4/526 Clinical Science Center, 600 Highland Avenue, Madison, Wisconsin 53792. 

Phrase: "Anath Shalev,"

Phrase: "University of Wisconsin-Madison,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0041740:University [Manufactured Object,Organization]
   812   C0043193:Wisconsin [Geographic Area]

Phrase: "H4/526 Clinical Science Center,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C2347782:Clinical Center [Organization]
   804   C0205099:Center [Spatial Concept]

Phrase: "600 Highland Avenue,"

Phrase: "Madison,"

Phrase: "Wisconsin 53792."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043193:Wisconsin [Geographic Area]
Processing 00000000.tx.10: E-mail: as7{at}medicine.wisc.edu .  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Type 2 diabetes occurs when pancreatic -cells become unable to compensate for the underlying insulin resistance. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "as7{at}medicine.wisc.edu .  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   787   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "when"

Phrase: "pancreatic -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "become"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "compensate for the underlying insulin resistance."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0021655:Insulin Resistance [Pathologic Function]
   790   C2700570:INSULIN RESISTANCE [Gene or Genome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0205432:compensate [Qualitative Concept]
   753   C0237834:Resistance [Mental Process]
   753   C1514892:Resistance [Physiologic Function]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.11: Insulin secretion requires -cell insulin stores to be replenished by insulin biosynthesis, which is mainly regulated at the translational level. 

Phrase: "Insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "requires -"

Phrase: "cell insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "stores"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1698986:Store [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "replenished by insulin biosynthesis,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0005572:biosynthesis [Functional Concept]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0220781:Biosynthesis [Biologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "which"

Phrase: "is"

Phrase: "mainly"

Phrase: "regulated at the translational level."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C1519614:Translational [Genetic Function]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.12: Such translational regulation often involves the 5'-untranslated region. 

Phrase: "Such translational regulation often"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C3537096:Translational Regulation [Genetic Function]
   827   C0851285:Regulation [Governmental or Regulatory Activity]
   827   C1327622:Regulation [Biologic Function]

Phrase: "involves"

Phrase: "the 5'-untranslated region."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0600493:5' Untranslated Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   913   C1883644:5' Region [Nucleotide Sequence]
   901   C0600680:Untranslated Region [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.13: Recently, we identified a human insulin splice-variant (SPV) altering only the 5'-untranslated region and conferring increased translation efficiency. 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "we"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "a human insulin splice-variant (SPV) altering only"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   706   C0392747:Altered [Functional Concept]

Phrase: "the 5'-untranslated region"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0600493:5' Untranslated Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   913   C1883644:5' Region [Nucleotide Sequence]
   901   C0600680:Untranslated Region [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "conferring increased translation efficiency."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0013682:Efficiency [Quantitative Concept]
   741 E C0442799:Efficient [Qualitative Concept]
Processing 00000000.tx.14: We now describe a mouse SPV (mSPV) that is found in the cytoplasm and exhibits increased translation efficiency resulting in more normal (prepro)insulin protein per RNA. 

Phrase: "We now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "describe"

Phrase: "a mouse SPV (SPV)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variant [Qualitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "found in the cytoplasm"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0010834:Cytoplasm [Cell Component]
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "increased translation efficiency"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0013682:Efficiency [Quantitative Concept]
   755 E C0442799:Efficient [Qualitative Concept]

Phrase: "resulting in more normal"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0332294:Resulting in [Functional Concept]
   802   C0459422:Normal result [Finding]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C0678226:resulting [Functional Concept]
   770   C2347086:% Normal [Quantitative Concept]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "(prepro)insulin protein per RNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.15: The RNA stability of mSPV is not increased, but the predicted secondary RNA structure is altered, which may facilitate translation. 

Phrase: "The RNA stability of mSPV"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0752249:RNA Stability [Qualitative Concept]
   753   C0205360:Stability [Qualitative Concept]
   753   C2347098:Stability [Qualitative Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: ","

Phrase: "but"

Phrase: "the predicted secondary RNA structure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0162807:Secondary Structure [Spatial Concept]
   812   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0678594:Structure [Spatial Concept]

Phrase: "is"

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: ","

Phrase: "which"

Phrase: "may"

Phrase: "facilitate"

Phrase: "translation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040712:Translation [Intellectual Product]
  1000   C0597295:translation [Molecular Function]
  1000   C1519614:Translation [Genetic Function]
Processing 00000000.tx.16: To determine the role of mSPV in insulin resistance and diabetes, mSPV expression was measured by quantitative real-time RT-PCR in islets from three diabetic and/or insulin-resistant, obese and nonobese, mouse models (BTBRob/ob, C57BL/6ob/ob, and C57BL/6azip). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the role of mSPV"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "mSPV expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "measured by quantitative real-time RT-PCR"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   804   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   804   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   778   C0599161:RT-PCR [Molecular Biology Research Technique]
   778   C1550177:Real Time [Idea or Concept]
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0040223:Time [Temporal Concept]
   748   C0237400:Real [Qualitative Concept]
   748   C0392762:Quantitative [Quantitative Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C0677874:pCR [Finding]
   748   C3272377:REAL [Intellectual Product]
   748   C3541383:Time [Temporal Concept]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]

Phrase: "in islets"

Phrase: "from three diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0241863:DIABETIC [Finding]

Phrase: "and/or"

Phrase: "insulin-resistant, obese"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0028754:Obese [Disease or Syndrome]

Phrase: "and"

Phrase: "nonobese, mouse models"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C2986594:Mouse Model [Experimental Model of Disease]
   827   C3161035:Models [Intellectual Product]

Phrase: "(BTBRob/ob,"

Phrase: "C57BL/6ob/ob,"

Phrase: "and"

Phrase: "C57BL/6azip"

Phrase: ")."
Processing 00000000.tx.17: Interestingly, mSPV expression was significantly higher in all diabetic/insulin-resistant mice compared with wild-type littermates and was dramatically induced in primary mouse islets incubated at high glucose. 

Phrase: "Interestingly,"

Phrase: "mSPV expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "significantly higher in all diabetic/insulin-resistant mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   750   C0020459:high insulin [Disease or Syndrome]
   711   C0205250:High [Qualitative Concept]
   711   C1299351:High [Qualitative Concept]
   711   C2700149:HIGH [Intellectual Product]

Phrase: "compared with wild-type littermates"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "was"

Phrase: "dramatically"

Phrase: "induced in primary mouse islets"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C1522528:Mouse Islets [Tissue]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C0205225:Primary [Qualitative Concept]
   760   C0205263:Induced [Functional Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]

Phrase: "incubated at high glucose."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0860803:high glucose [Finding]
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0205250:High [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.18: This raises the possibility that the mSPV may represent a compensatory -cell mechanism to enhance insulin biosynthesis when insulin requirements are elevated by hyperglycemia/insulin resistance.  

Phrase: "This"

Phrase: "raises"

Phrase: "the possibility"

Phrase: "that"

Phrase: "the mSPV"

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a compensatory -cell mechanism to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0441712:Mechanism [Functional Concept]
   812   C1706376:Mechanism [Manufactured Object]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "insulin biosynthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005572:biosynthesis [Functional Concept]
   861   C0220781:Biosynthesis [Biologic Function]

Phrase: "when"

Phrase: "insulin requirements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514873:Requirement [Functional Concept]

Phrase: "are"

Phrase: "elevated by hyperglycemia/insulin resistance."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   806   C0021655:Insulin Resistance [Pathologic Function]
   806   C2700570:INSULIN RESISTANCE [Gene or Genome]
   760   C0020456:Hyperglycaemia [Disease or Syndrome]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0205250:Elevated [Qualitative Concept]
   760   C0237834:Resistance [Mental Process]
   760   C1514892:Resistance [Physiologic Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C3163633:Elevated [Qualitative Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.19: INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  TYPE 2 DIABETES ensues when peripheral insulin resistance can no longer be compensated by increased insulin secretion and biosynthesis. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TYPE 2 DIABETES"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "ensues"

Phrase: "when"

Phrase: "peripheral insulin resistance"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   913   C1258192:Peripheral Resistance [Physiologic Function]
   901   C0021655:Insulin Resistance [Pathologic Function]
   901   C2700570:INSULIN RESISTANCE [Gene or Genome]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0237834:Resistance [Mental Process]
   827   C1514892:Resistance [Physiologic Function]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   755 E C0332325:Resistant [Functional Concept]
   755 E C1550464:resistent [Idea or Concept]
   755 E C2827757:RESISTANT [Laboratory or Test Result]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "can"

Phrase: "no longer"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0205166:Long [Qualitative Concept]
   966   C1706317:Long [Qualitative Concept]
   916 E C1444754:Length [Quantitative Concept]
   916 E C1706316:LENGTH [Research Activity]

Phrase: "be"

Phrase: "compensated by increased insulin secretion"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   862   C1372360:Increased Insulin Secretion [Organ or Tissue Function]
   806   C0020459:increased insulin [Disease or Syndrome]
   806   C1256369:insulin secretion [Cell Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C0205217:Increased [Quantitative Concept]
   760   C0205432:Compensated [Qualitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "biosynthesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005572:biosynthesis [Functional Concept]
  1000   C0220781:Biosynthesis [Biologic Function]
Processing 00000000.tx.20: The ability of the pancreatic -cell to increase insulin secretion requires continuous replenishment of the insulin stores by insulin biosynthesis. 

Phrase: "The ability of the pancreatic -cell to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0085732:Ability [Organism Attribute]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "requires"

Phrase: "continuous replenishment of the insulin"

Phrase: "stores by insulin biosynthesis."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0005572:biosynthesis [Functional Concept]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0220781:Biosynthesis [Biologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1698986:Store [Functional Concept]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.21: Previous studies have shown that glucose-induced insulin biosynthesis is mainly regulated at the translational level (1, 2, 3, 4, 5). 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that glucose-induced insulin biosynthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0017715:glucose biosynthesis [Molecular Function]
   812   C0005572:biosynthesis [Functional Concept]
   812   C0220781:Biosynthesis [Biologic Function]
   708   C1719133:Glucose/Insulin [Quantitative Concept]

Phrase: "is"

Phrase: "mainly"

Phrase: "regulated at the translational level"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C1519614:Translational [Genetic Function]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.22: However, our knowledge of the mechanisms involved in translational regulation of insulin biosynthesis is limited. 

Phrase: "However,"

Phrase: "our knowledge of the mechanisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0376554:Knowledge [Intellectual Product]

Phrase: "involved in translational regulation of insulin biosynthesis"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   804   C1157723:regulation of biosynthesis [Molecular Function]
   781   C1157519:regulation of translation [Cell Function]
   778   C3537096:Translational Regulation [Genetic Function]
   748   C0005572:biosynthesis [Functional Concept]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0220781:Biosynthesis [Biologic Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1314939:Involved [Functional Concept]
   748   C1327622:Regulation [Biologic Function]
   748   C1519614:Translational [Genetic Function]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "is"

Phrase: "limited."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0439801:Limited [Functional Concept]
  1000   C3542948:Limited [Intellectual Product]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]
Processing 00000000.tx.23: Translational regulation of a particular mRNA often involves the 5'-untranslated region (5'UTR) of the gene (6, 7, 8, 9). 

Phrase: "Translational regulation of a particular mRNA often"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C1157519:regulation of translation [Cell Function]
   778   C3537096:Translational Regulation [Genetic Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "involves"

Phrase: "the 5'-untranslated region"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0600493:5' Untranslated Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   913   C1883644:5' Region [Nucleotide Sequence]
   901   C0600680:Untranslated Region [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "(5'UTR) of the gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0600493:5' UTR [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0600680:UTR [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1420099:UTR [Gene or Genome]
   760   C1540171:UTR [Gene or Genome]

Phrase: "(6,"

Phrase: "7,"

Phrase: "8,"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.24: The insulin gene consists of three exons and two introns, and the 5'UTR includes exon 1 and part of exon 2, because the coding region starts in exon 2. 

Phrase: "The insulin gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1337112:Insulin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "consists of three exons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0205449:Three [Quantitative Concept]
   770   C0332529:CONSIST [Qualitative Concept]

Phrase: "and"

Phrase: "two introns,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Introns [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "the 5'UTR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0600493:5' UTR [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0600680:UTR [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1420099:UTR [Gene or Genome]
   861   C1540171:UTR [Gene or Genome]

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "exon 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "part of exon 2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1292711:Part of [Spatial Concept]
   770   C0449719:Part [Spatial Concept]
   770   C1709471:Part [Quantitative Concept]

Phrase: "because"

Phrase: "the coding region"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0079941:Coding Region [Gene or Genome]
   861   C0009219:Coding [Occupational Activity]
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   827 E C0805701:Code [Intellectual Product]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "starts in exon 2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0439659:Start [Temporal Concept]
Processing 00000000.tx.25: Both introns are flanked by canonical splice sites, but in addition, intron 1 was found to contain a cryptic 5' splice site (10). 

Phrase: "Both introns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021920:Introns [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "flanked by canonical splice sites,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0205145:Sites [Spatial Concept]
   726   C0230171:Flank [Body Location or Region]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]

Phrase: "but in addition,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0233535:but [Mental or Behavioral Dysfunction]
   790   C1883712:Addition [Functional Concept]
   718 E C1524062:Additional [Functional Concept]

Phrase: "intron 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a cryptic 5' splice site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1720838:Splice Site, Cryptic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0205145:Site [Spatial Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.26: Because this splice site lies within the 5'UTR region, alternative splicing using this site gives rise to a splice-variant (SPV; GenBank accession no. AY899304) without affecting the coding region. 

Phrase: "Because"

Phrase: "this splice site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "lies within the 5'UTR region,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]
   753   C0600680:UTR [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C1420099:UTR [Gene or Genome]
   753   C1540171:UTR [Gene or Genome]

Phrase: "alternative splicing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002345:Alternative Splicing [Genetic Function]
   861   C0035687:Splicing [Genetic Function]
   861   C2610186:splicing [Genetic Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205145:Site [Spatial Concept]
  1000   C1515974:Site [Body Location or Region]
  1000   C2825164:Site [Spatial Concept]

Phrase: "gives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "rise to a splice-variant"

Phrase: "(SPV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "; GenBank accession"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1510755:Accession [Intellectual Product]
   861   C1706078:Accession [Activity]

Phrase: "no. AY899304"

Phrase: ")"

Phrase: "without affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the coding region."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0079941:Coding Region [Gene or Genome]
   861   C0009219:Coding [Occupational Activity]
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   827 E C0805701:Code [Intellectual Product]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.27: This SPV is expressed in normal human islets and demonstrates increased translation efficiency both in vitro and in vivo (10). 

Phrase: "This SPV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "is"

Phrase: "expressed in normal human islets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0086418:Human [Human]
   760   C0205307:Normal [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "demonstrates"

Phrase: "increased translation efficiency"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0013682:Efficiency [Quantitative Concept]
   755 E C0442799:Efficient [Qualitative Concept]

Phrase: "both in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.28: In addition, glucose increases SPV expression in a time-dependent manner. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "SPV expression in a time-dependent manner."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.29: This suggests that enhanced SPV expression may represent a compensatory mechanism in response to prolonged hyperglycemia or increased insulin requirements by generating more insulin protein from less mRNA in times of increased demand (10). 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that enhanced SPV expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a compensatory mechanism in response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "to prolonged hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "or"

Phrase: "increased insulin requirements by generating more insulin protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0556043:protein requirements [Finding]
   750   C0520917:Increased requirement [Pathologic Function]
   711   C1514873:Requirement [Functional Concept]

Phrase: "from less mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:times [Temporal Concept]
  1000   C1632851:Times [Quantitative Concept]
   966 E C3541383:Time [Temporal Concept]
   928 E C0442043:Temporal [Spatial Concept]
   928 E C2362314:Temporal [Temporal Concept]

Phrase: "of increased demand"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441516:Demand [Therapeutic or Preventive Procedure]
   861   C0699784:demand [Idea or Concept]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.30: We therefore hypothesized that SPV expression may be involved in -cell adaptation to the increased insulin requirements of obesity, insulin resistance, and diabetes. 

Phrase: "We therefore"

Phrase: "hypothesized"

Phrase: "that SPV expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "be"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "in -cell adaptation to the increased insulin requirements of obesity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0000934:adaptation [Organism Function]
   739   C0392673:Adaptation [Biologic Function]

Phrase: "insulin resistance,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.31: The goal of the present study was to test this hypothesis and to gain a better understanding of the role of this recently described insulin SPV. 

Phrase: "The goal of the present study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0018017:Goal [Intellectual Product]
   753   C1571704:Goal [Idea or Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "gain"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1517378:Gain [Quantitative Concept]
   944 E C0205217:Increased [Quantitative Concept]
   944 E C0439661:Acquired [Temporal Concept]
   944 E C0442805:Increase [Functional Concept]
   944 E C0442808:Increasing [Functional Concept]
   944 E C1301820:Obtain [Functional Concept]
   944 E C1706701:Acquire [Activity]
   944 E C3245488:acquired [Intellectual Product]

Phrase: "a better understanding of the role"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0162340:Understanding [Mental Process]

Phrase: "of this recently described insulin SPV."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0205419:Variant [Qualitative Concept]
Processing 00000000.tx.32: To this end we characterized a mouse SPV (mSPV; GenBank accession no. AY899305) and by analyzing its expression, structure, and translational efficiency found it to be functionally very similar to the human SPV. 

Phrase: "To this end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "we"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "a mouse SPV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variant [Qualitative Concept]

Phrase: "(mSPV"

Phrase: "; GenBank accession"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1510755:Accession [Intellectual Product]
   861   C1706078:Accession [Activity]

Phrase: "no. AY899305"

Phrase: ")"

Phrase: "and by analyzing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "its expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "structure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "translational efficiency"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013682:Efficiency [Quantitative Concept]
   789 E C0442799:Efficient [Qualitative Concept]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "it to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "functionally very similar to the human SPV."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.33: This enabled us to study insulin SPV expression in obese and nonobese mouse models of insulin resistance and diabetes.  

Phrase: "This enabled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0562342:Enabled [Mental Process]
   966 E C1171285:enable [Mental Process]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "insulin SPV expression in obese"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "nonobese mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: "models of insulin resistance"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C3161035:Model [Intellectual Product]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.34: RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Expression of a mSPV Retaining Intron 1 in the 5'UTR Similar to the human insulin gene, the mouse homologue (mouse insulin 2 gene) is also alternatively spliced, as demonstrated by RT-PCR using mouse insulin 2 cloning primers and cDNA derived from healthy mouse pancreata (Fig. 1B). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Expression of a mSPV Retaining Intron 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the 5'UTR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0600493:5' UTR [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0600680:UTR [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1420099:UTR [Gene or Genome]
   861   C1540171:UTR [Gene or Genome]

Phrase: "Similar to the human insulin gene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "the mouse homologue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1334043:Homologue [Gene or Genome]

Phrase: "(mouse insulin 2 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C1337112:Insulin Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]

Phrase: ")"

Phrase: "is"

Phrase: "also alternatively"

Phrase: "spliced"

Phrase: ","

Phrase: "as"

Phrase: "demonstrated by RT-PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0599161:RT-PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "mouse insulin 2 cloning primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "derived from healthy mouse pancreata"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1518865:Mouse Pancreas [Tissue]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C1441547:Derived [Qualitative Concept]
   760   C3245521:derived [Idea or Concept]
   726   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   726   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.35: Compared with the human SPV (10), the mSPV is significantly larger, and subcloning and sequencing revealed that the mSPV is generated by retention of the whole 102-bp intron (Fig. 1A), in contrast to the small 26-bp intronic sequence retained in humans. 

Phrase: "Compared with the human SPV"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0086418:Human [Human]
   753   C0205419:Variant [Qualitative Concept]
   753   C1707455:Compared [Activity]

Phrase: "(10"

Phrase: ")"

Phrase: ","

Phrase: "the mSPV"

Phrase: "is"

Phrase: "significantly larger,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0443228:larger [Quantitative Concept]
   861   C0549177:Larger [Quantitative Concept]
   861   C1704243:Larger [Quantitative Concept]

Phrase: "and"

Phrase: "subcloning"

Phrase: "and"

Phrase: "sequencing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1553778:Sequencing [Intellectual Product]
  1000   C1561491:Sequencing [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the mSPV"

Phrase: "is"

Phrase: "generated by retention of the whole 102-bp intron"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0035280:Retention [Mental Process]
   742   C0333117:Retention [Functional Concept]
   742   C0444667:Whole [Quantitative Concept]
   742   C1753315:retention [Cell Function]
   742   C3146294:Generated [Activity]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "in contrast to the small 26-bp intronic sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   804   C0004793:Sequence [Nucleotide Sequence]
   804   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0162326:Sequence [Nucleotide Sequence]
   804   C0162327:Sequence [Nucleotide Sequence]
   804   C1519249:Sequence [Functional Concept]
   733 E C1548958:Sequential [Idea or Concept]
   733 E C1705294:Sequential [Qualitative Concept]

Phrase: "retained in humans."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0086418:Humans [Human]
   790   C0333118:Retained [Functional Concept]
Processing 00000000.tx.36: This suggests that although a putative 5' splice site sequence (AGGT) is present in intron 1 (Fig. 1A), it is not used in mice. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "although"

Phrase: "a putative 5' splice site sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   804   C0004793:Sequence [Nucleotide Sequence]
   804   C0162326:Sequence [Nucleotide Sequence]
   804   C0162327:Sequence [Nucleotide Sequence]
   804   C1519249:Sequence [Functional Concept]
   733 E C1548958:Sequential [Idea or Concept]
   733 E C1705294:Sequential [Qualitative Concept]

Phrase: "(AGGT"

Phrase: ")"

Phrase: "is"

Phrase: "present in intron 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "used in mice."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.37: No other SPVs could be detected, and using nonselective primers outside any exon-exon or exon-intron boundaries, only native insulin (mNAT) and the described mSPV were amplified (Fig. 1C). 

Phrase: "No"

Phrase: "other SPVs"

Phrase: "could"

Phrase: "be"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ","

Phrase: "and"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "nonselective primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "outside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205101:Outside [Spatial Concept]

Phrase: "any exon-exon"

Phrase: "or"

Phrase: "exon-intron boundaries,"

Phrase: "only native insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(mNAT"

Phrase: ")"

Phrase: "and"

Phrase: "the described mSPV"

Phrase: "were"

Phrase: "amplified"

Phrase: "(Fig. 1C"

Phrase: ")."
Processing 00000000.tx.38: The expression of the predicted mSPV was also confirmed by Northern blotting (Fig. 2). 

Phrase: "The expression of the predicted mSPV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "also"

Phrase: "confirmed by Northern blotting"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0005861:Northern Blotting [Molecular Biology Research Technique]
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   816 E C1621557:Northern Blot [Research Device]
   770   C0750484:Confirmed [Idea or Concept]
   770   C1709269:Northern [Spatial Concept]
   737 E C1456348:Confirm [Qualitative Concept]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.39: In addition, sequence analysis demonstrated that intron 2 is correctly spliced out and that this mSPV is derived from the mouse insulin 2, not insulin 1, gene (Fig. 1A). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "sequence analysis"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C0936012:Analysis [Research Activity]
   861   C1519249:Sequence [Functional Concept]
   861   C1524024:analysis [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "demonstrated"

Phrase: "that intron 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "correctly"

Phrase: "spliced"

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "and"

Phrase: "that"

Phrase: "this mSPV"

Phrase: "is"

Phrase: "derived from the mouse insulin 2,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C1441547:Derived [Qualitative Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C3245521:derived [Idea or Concept]

Phrase: "not insulin 1,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1518422:Not [Functional Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.40: View larger version (17K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.41: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.42: Mouse (Prepro)Insulin 2 Gene SPV A, Sequence of intron 1 retained in the 5'UTR of the mouse insulin 2 gene SPV. 

Phrase: "Mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "(Prepro)Insulin 2 Gene SPV A,"

Phrase: "Sequence of intron 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C1519249:Sequence [Functional Concept]

Phrase: "retained in the 5'UTR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0333118:Retained [Functional Concept]
   760   C0600680:UTR [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1420099:UTR [Gene or Genome]
   760   C1540171:UTR [Gene or Genome]

Phrase: "of the mouse insulin 2 gene SPV."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0205419:Variant [Qualitative Concept]
Processing 00000000.tx.43: Exonic sequences are in capital letters, the 102 bp of intron 1 are framed, and the beginning of the coding region is symbolized by the ATG start codon. 

Phrase: "Exonic sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "are in capital letters,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   816   C2827599:Capital Letter [Qualitative Concept]
   770   C0006909:Capital [Quantitative Concept]
   770   C0282413:letters [Intellectual Product]
   770   C1551058:Are [Quantitative Concept]
   737 E C1096774:Letter [Intellectual Product]
   737 E C2360551:Letter [Clinical Attribute]

Phrase: "the 102 bp of intron 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   783   C2984182:BP-1 [Gene or Genome]

Phrase: "are"

Phrase: "framed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0080089:Frame [Nucleotide Sequence]
   966   C0180979:Frame [Medical Device]
   966   C1705858:Frame [Manufactured Object]

Phrase: ","

Phrase: "and"

Phrase: "the beginning of the coding region"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439659:Beginning [Temporal Concept]

Phrase: "is"

Phrase: "symbolized by the ATG start codon."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0242610:Codon, Start [Nucleotide Sequence]
   753   C0009221:Codon [Nucleotide Sequence]
   753   C0439659:Start [Temporal Concept]
   753   C1095825:Codon [Plant]
Processing 00000000.tx.44: Gray boxes mark mouse insulin 2 gene-specific base pairs (distinct from insulin 1 gene). 

Phrase: "Gray boxes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0179400:boxes [Manufactured Object]
   861   C1638312:Boxes [Quantitative Concept]
   827 E C1533124:Box [Medical Device]

Phrase: "mark"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:mark [Qualitative Concept]

Phrase: "mouse insulin 2 gene-specific base pairs"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   818   C0600436:Base Pairs [Molecular Function]
   795   C0002055:base [Inorganic Chemical]
   795   C0178499:Base [Chemical Viewed Functionally]
   795   C1709450:Pair [Qualitative Concept]
   795   C1880279:Base [Biomedical or Dental Material]
   724 E C0205112:Basal [Spatial Concept]
   712 E C0016617:Foundation [Organization]
   712 E C1626935:Bases [Quantitative Concept]

Phrase: "(distinct from insulin 1 gene"

Phrase: ")."
Processing 00000000.tx.45: The position of the primers used for the RT-PCRs demonstrated in B and C are shown by arrows, and numbers in brackets correspond to the primer numbers of Table 1. 

Phrase: "The position of the primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0733755:Position [Spatial Concept]

Phrase: "used for the RT-PCRs"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   773   C0599161:RT-PCR [Molecular Biology Research Technique]
   760   C1273517:used [Finding]
   726   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726   C0677874:pCR [Finding]
   726 E C1947944:Use [Intellectual Product]

Phrase: "demonstrated in B"

Phrase: "and"

Phrase: "C"

Phrase: "are"

Phrase: "shown by arrows,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0336721:arrows [Manufactured Object]
   756   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "numbers in brackets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0237753:*Number [Quantitative Concept]
   790   C0449788:Number [Quantitative Concept]

Phrase: "correspond to the primer numbers of Table 1."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0039224:Table [Manufactured Object]
   744   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]
   744   C1706073:Table [Medical Device]
   744   C1706074:Table [Intellectual Product]
Processing 00000000.tx.46: The asterisk marks a potential AGGT splice site within intron 1. 

Phrase: "The asterisk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisk [Conceptual Entity]

Phrase: "marks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:mark [Qualitative Concept]

Phrase: "a potential AGGT splice site within intron 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0205145:Site [Spatial Concept]
   744   C1515974:Site [Body Location or Region]
   744   C2825164:Site [Spatial Concept]
Processing 00000000.tx.47: B, RT-PCR of mNAT and mSPV, using RNA of normal mouse pancreas as a template. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "RT-PCR of mNAT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0599161:RT-PCR [Molecular Biology Research Technique]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]

Phrase: "and"

Phrase: "mSPV,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "RNA of normal mouse pancreas"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "as a template."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0728990:TEMPLATE [Medical Device]
  1000   C1514575:Template [Conceptual Entity]
  1000   C1705542:Template [Idea or Concept]
Processing 00000000.tx.48: The exon 1-exon 2-spanning primer (1 ) was used for mNAT, and the exon 1-intron 1-spanning primer (2 ) was used for mSPV; 

Phrase: "The exon 1-exon 2-spanning primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "was"

Phrase: "used for mNAT,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "the exon 1-intron 1-spanning primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "was"

Phrase: "used for mSPV"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.49: the 3' primer (3 ) in exon 3 (not shown) was used for both reactions. 

Phrase: "the 3' primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "in exon 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "was"

Phrase: "used for both reactions."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737   C0443286:Reaction [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737   C1114821:Reaction [Clinical Attribute]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.50: Bands represent 10 l PCR product run on an ethidium-stained 3% agarose gel. 

Phrase: "Bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "10 l PCR product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1514468:product [Entity]
   812   C1704444:Product [Quantitative Concept]

Phrase: "run on"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0035953:run [Daily or Recreational Activity]
   861   C0600140:run [Finding]
   861   C1704688:Run [Functional Concept]
   861   C2346414:Run [Finding]

Phrase: "an ethidium-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]

Phrase: "stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "3% agarose gel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1706746:Agarose Gel [Research Device]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C1382104:Gel [Substance]
Processing 00000000.tx.51: No additional bands were seen, and sequencing confirmed that the larger size of the mSPV was due to retention of the whole 102-bp intron 1. 

Phrase: "No additional bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: ","

Phrase: "and"

Phrase: "sequencing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1553778:Sequencing [Intellectual Product]
  1000   C1561491:Sequencing [Functional Concept]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the larger size of the mSPV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0456389:size [Spatial Concept]

Phrase: "was due to retention of the whole 102-bp intron 1."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   756   C0678226:Due to [Functional Concept]
           due
   754   C2984182:BP-1 [Gene or Genome]
   738   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0035280:Retention [Mental Process]
   738   C0043194:WAS [Disease or Syndrome]
   738   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0333117:Retention [Functional Concept]
   738   C0444667:Whole [Quantitative Concept]
   738   C1421478:WAS [Gene or Genome]
   738   C1753315:retention [Cell Function]
   738   C3146286:Due [Idea or Concept]
Processing 00000000.tx.52: C, Simultaneous RT-PCR of mNAT and mSPV in the same reaction using the nonselective exon 1 5' primer (4 ) (lane 3). 

Phrase: "C,"

Phrase: "Simultaneous RT-PCR of mNAT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0599161:RT-PCR [Molecular Biology Research Technique]
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0677874:pCR [Finding]

Phrase: "and"

Phrase: "mSPV in the same reaction"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the nonselective exon 1 5' primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(4"

Phrase: ")"

Phrase: "(lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.53: As a comparison, mNAT (lane 1) and mSPV (lane 2) RT-PCR products generated as described in B are shown. 

Phrase: "As a comparison,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "mNAT"

Phrase: "(lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "mSPV (lane 2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0025914:Mouse [Mammal]
   812   C0025929:mouse [Mammal]
   812   C0026809:Mouse [Mammal]
   812   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "RT-PCR products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]
   734   C0599161:RT-PCR [Molecular Biology Research Technique]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "as"

Phrase: "described in B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.54: The one larger and fainter band in lane 3 corresponds to the mSPV in lane 2. 

Phrase: "The one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "larger"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0443228:larger [Quantitative Concept]
  1000   C0549177:Larger [Quantitative Concept]
  1000   C1704243:Larger [Quantitative Concept]

Phrase: "and"

Phrase: "fainter band in lane 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0175723:Band [Medical Device]
   760   C0439645:Band [Spatial Concept]
   760   C1521913:band [Cell Component]

Phrase: "corresponds to the mSPV"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]

Phrase: "in lane 2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]
Processing 00000000.tx.55: For all three reactions, RNA extracted from Min6 -cells was used.  

Phrase: "For all three reactions,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "extracted from Min6 -cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C3282337:Cells [Cell]
   770   C3541890:EXTRACTED [Finding]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737 E C2828366:Extract [Substance]

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.56: View larger version (62K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(62K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.57: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.58: Northern Blot of mSPV Northern blotting was performed as described in Materials and Methods. 

Phrase: "Northern Blot of mSPV Northern blotting"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0005861:Northern Blot [Molecular Biology Research Technique]
           Northern Blotting
   778   C1621557:Northern Blot [Research Device]
   748   C1709269:Northern [Spatial Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.59: RNA from Min6 -cells was run in lanes 2 and 3, and lanes 1 and 4 represent negative controls using RNA from the 293 non--cell line; 

Phrase: "RNA from Min6 -cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "run in lanes 2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C3274438:RUN-IN [Temporal Concept]
   812   C0035953:run [Daily or Recreational Activity]
   812   C0600140:run [Finding]
   812   C1704688:Run [Functional Concept]
   812   C2346414:Run [Finding]
   779   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "lanes 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "4"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "negative controls"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   966   C1639518:% negative control [Quantitative Concept]
   966   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "RNA from the 293 non"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "--"

Phrase: "cell line"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0007600:Cell Line [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:Line [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.60: 20 g total RNA were loaded per lane. 

Phrase: "20 g total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "loaded per lane."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1708639:Lane [Spatial Concept]
   790   C1708715:Loaded [Activity]
   756 E C1550025:Load [Idea or Concept]
   756 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.61: Half the membrane was probed with the mNAT-specific probe spanning exon 1-exon 2, and half was probed with the mSPV-specific probe within intron 1. 

Phrase: "Half"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825407:Half [Quantitative Concept]

Phrase: "the membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "probed with the mNAT-specific probe spanning exon 1-exon 2,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   738   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0205369:Specific [Qualitative Concept]
   738   C1552740:specific [Intellectual Product]
   704   C0182400:Probe [Medical Device]
   704   C1704681:Probe [Gene or Genome]
   704   C1711300:Span [Conceptual Entity]
   704   C2347609:Probe [Chemical Viewed Functionally]
   704   C2700613:Span [Quantitative Concept]
   704   C3536729:Probe [Manufactured Object]

Phrase: "and"

Phrase: "half"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825407:Half [Quantitative Concept]

Phrase: "was"

Phrase: "probed with the mSPV-specific probe"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0025914:Mouse [Mammal]
   748   C0025929:mouse [Mammal]
   748   C0026809:Mouse [Mammal]
   748   C0205369:Specific [Qualitative Concept]
   748   C1552740:specific [Intellectual Product]
   714   C0182400:Probe [Medical Device]
   714   C1704681:Probe [Gene or Genome]
   714   C2347609:Probe [Chemical Viewed Functionally]
   714   C3536729:Probe [Manufactured Object]

Phrase: "within intron 1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.62: In lane 3, the slightly larger and fainter band compared with the band in lane 2 is consistent with the predicted mSPV RNA.  

Phrase: "In lane 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "the slightly larger"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0443228:larger [Quantitative Concept]
   861   C0549177:Larger [Quantitative Concept]
   861   C1704243:Larger [Quantitative Concept]

Phrase: "and"

Phrase: "fainter band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: "compared with the band"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0175723:Band [Medical Device]
   770   C0439645:Band [Spatial Concept]
   770   C1521913:band [Cell Component]
   770   C1707455:Compared [Activity]

Phrase: "in lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "is"

Phrase: "consistent with the predicted mSPV RNA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.63: Insulin SPV Is Translated More Efficiently into Native (Prepro)Insulin Protein To compare the translation efficiency of the newly identified mSPV with mNAT, we used in vitro translation assays, as described in Materials and Methods. 

Phrase: "Insulin SPV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variant [Qualitative Concept]

Phrase: "Is"

Phrase: "Translated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040710:translated [Occupational Activity]

Phrase: "More Efficiently into Native"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205172:More [Functional Concept]
   770   C0302891:Native [Functional Concept]

Phrase: "(Prepro)Insulin Protein To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the translation efficiency of the newly identified mSPV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0013682:Efficiency [Quantitative Concept]

Phrase: "with mNAT,"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "in vitro translation assays,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   906   C1515653:In Vitro Assay [Research Activity]
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.64: The results demonstrated that the SPV yielded 2.4-fold more (prepro)insulin protein than mNAT (Fig. 3, A and B). 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the SPV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "yielded"

Phrase: "2.4-fold more"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332462:Fold [Spatial Concept]
   812   C1880834:FOLD [Phenomenon or Process]

Phrase: "(prepro)insulin protein than mNAT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.65: In addition, we generated reporter constructs to analyze the effects of the mSPV 5'UTR in vivo. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "reporter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0335038:Reporter [Professional or Occupational Group]
  1000   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
  1000   C1705915:Reporter [Conceptual Entity]
  1000   C1709908:Reporter [Group]

Phrase: "constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "analyze"

Phrase: "the effects of the mSPV 5'UTR"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.66: In these transfection experiments, the presence of the 102-bp intronic sequence in the mSPV 5'UTR led to a small, but highly significant, increase in translation efficiency (P = 0.0002) compared with the mNAT 5'UTR and determined by luciferase activity (Fig. 3C). 

Phrase: "In these transfection experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "the presence of the 102-bp intronic sequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the mSPV 5'UTR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0600680:UTR [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1420099:UTR [Gene or Genome]
   812   C1540171:UTR [Gene or Genome]

Phrase: "led to a small,"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   770   C0700321:Small [Quantitative Concept]
   770   C1708698:LED [Manufactured Object]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C1522538:Lead [Functional Concept]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "but"

Phrase: "highly significant, increase in translation efficiency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "(P = 0.0002"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "compared with the mNAT 5'UTR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0600680:UTR [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C1420099:UTR [Gene or Genome]
   753   C1540171:UTR [Gene or Genome]
   753   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "determined by luciferase activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1151115:luciferase activity [Molecular Function]
   770   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.67: View larger version (17K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.68: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.69: Translation Efficiency of mSPV A, Radiograph of in vitro translated [35S]methionine-labeled (prepro)insulin using exactly the same amounts of RNA, mNAT (lane 2), and mSPV (lane 3) or no RNA (lane 1). 

Phrase: "Translation Efficiency of mSPV A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0013682:Efficiency [Quantitative Concept]

Phrase: "Radiograph of in vitro translated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1306645:Radiograph [Diagnostic Procedure]
   760   C1548003:Radiograph [Intellectual Product]

Phrase: "[35S"

Phrase: "]methionine-labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1708632:Labeled [Qualitative Concept]
   827 E C0181496:Label [Manufactured Object]
   827 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(prepro)insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "exactly"

Phrase: "the same amounts of RNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "mNAT"

Phrase: "(lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "mSPV (lane 3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0025914:Mouse [Mammal]
   812   C0025929:mouse [Mammal]
   812   C0026809:Mouse [Mammal]
   812   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "no RNA (lane 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.70: The 12.5-l translation reactions were incubated for 40 min at 30 C, and 5 l were used for electrophoresis. 

Phrase: "The 12.5-l translation reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0443286:Reaction [Functional Concept]
   771   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "incubated for 40 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439509:/40 [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 30 C,"

Phrase: "and"

Phrase: "5 l"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348935:.5 L [Quantitative Concept]

Phrase: "were"

Phrase: "used for electrophoresis."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0013855:Electrophoresis [Laboratory Procedure]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.71: B, Quantification of translation efficiency of mNAT (), set at 1, and mSPV (). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Quantification of translation efficiency of mNAT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709793:Quantification [Quantitative Concept]

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: "set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "at 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: "and"

Phrase: "mSPV ("

Phrase: ")."
Processing 00000000.tx.72: Bars represent the mean fold change  SEM of six independent experiments using in vitro transcribed RNA from two different batches. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the mean fold change  SEM of six independent experiments"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "in vitro transcribed RNA from two different batches."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.73: C, Transfection study assessing mNAT and mSPV translation efficiencies in vivo. 

Phrase: "C,"

Phrase: "Transfection study assessing mNAT"

Phrase: "and"

Phrase: "mSPV translation efficiencies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0013682:efficiencies [Quantitative Concept]
   729 E C0442799:Efficient [Qualitative Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.74: The mNAT and mSPV 5'UTRs were cloned into the pGL3 control vector between the simian virus 40 promoter and luciferase reporter gene, yielding two constructs differing only in the absence or presence of the intronic 102 bp. 

Phrase: "The mNAT"

Phrase: "and"

Phrase: "mSPV 5'UTRs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0600680:UTR [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1420099:UTR [Gene or Genome]
   812   C1540171:UTR [Gene or Genome]

Phrase: "were"

Phrase: "cloned into the pGL3 control vector"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   790   C0031249:control vector [Occupational Activity]
   753   C0009013:cloned [Cell]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0243148:control [Qualitative Concept]
   753   C0442335:Vector [Spatial Concept]
   753   C1550141:Control [Substance]
   753   C1705099:Vector [Idea or Concept]
   753   C1854336:PGL3 [Disease or Syndrome]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3273620:PGL3 [Gene or Genome]
   753   C3274648:Control [Qualitative Concept]
   719 E C1522642:Clone [Tissue]

Phrase: "between the simian virus 40 promoter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756   C0038975:Simian virus 40 [Virus]

Phrase: "and"

Phrase: "luciferase reporter gene,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1334435:Luciferase Gene [Gene or Genome]
   901   C0206414:Reporter Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]

Phrase: "yielding"

Phrase: "two constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "differing"

Phrase: "only in the absence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205171:Only [Quantitative Concept]
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]
   770   C1720467:Only [Intellectual Product]

Phrase: "or"

Phrase: "presence of the intronic 102 bp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.75: Transfections were performed as described in Materials and Methods, and luciferase activity was assessed as a measure of translation efficiency. 

Phrase: "Transfections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "luciferase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1151115:luciferase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "assessed as a measure of translation efficiency."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0013682:Efficiency [Quantitative Concept]
   748   C0040712:Translation [Intellectual Product]
   748   C0079809:Measure [Quantitative Concept]
   748   C0242485:Measure [Functional Concept]
   748   C0597295:translation [Molecular Function]
   748   C1516048:Assessed [Activity]
   748   C1519614:Translation [Genetic Function]
Processing 00000000.tx.76: Bars represent fold changes in luciferase activity in cells transfected with the mSPV 5'UTR construct () compared with the mNAT 5'UTR (). 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332462:Fold [Spatial Concept]
  1000   C1880834:FOLD [Phenomenon or Process]

Phrase: "changes in luciferase activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C1151115:luciferase activity [Molecular Function]
   770   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   770   C0205177:Activity [Functional Concept]
   770   C0392747:Change [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C0443172:change [Quantitative Concept]
   770   C1561536:*Activity [Idea or Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with the mSPV 5'UTR construct"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]
   744   C0600680:UTR [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C1420099:UTR [Gene or Genome]
   744   C1540171:UTR [Gene or Genome]
   744   C2827421:Construct [Classification]

Phrase: "("

Phrase: ")"

Phrase: "compared with the mNAT 5'UTR ("
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0600680:UTR [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C1420099:UTR [Gene or Genome]
   753   C1540171:UTR [Gene or Genome]
   753   C1707455:Compared [Activity]

Phrase: ")."
Processing 00000000.tx.77: The mean  SEM of two independent experiments performed in triplicate are shown.  

Phrase: "The mean  SEM of two independent experiments"

Phrase: "performed in triplicate"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205174:Triplicate [Quantitative Concept]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.78: Cytoplasmic Localization of the Insulin SPV To address the question of whether, despite retention of intron 1, the mSPV is transported out of the nucleus into the cytoplasm and thereby becomes accessible for translation in vivo, we measured the mSPV/mNAT ratio by quantitative real-time RT-PCR in the cytoplasmic fraction of Min6 -cells. 

Phrase: "Cytoplasmic Localization of the Insulin SPV To"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0475264:Localisation [Functional Concept]
   744   C1744691:localisation [Biologic Function]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "the question of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1522634:Question [Intellectual Product]

Phrase: "whether"

Phrase: ","

Phrase: "despite retention"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035280:Retention [Mental Process]
  1000   C0333117:Retention [Functional Concept]
  1000   C1753315:retention [Cell Function]

Phrase: "of intron 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "the mSPV"

Phrase: "is"

Phrase: "transported out of the nucleus"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   781   C1526989:nucleus transport [Cell Function]
   760   C0007610:Nucleus [Cell Component]
   760   C0439787:Out [Spatial Concept]
   760   C0849355:Out [Qualitative Concept]
   726   C0005528:Transport, NOS [Cell Function]
   726   C1317949:Transport [Manufactured Object]
   726   C3495449:transport [Medical Device]

Phrase: "into the cytoplasm"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasm [Cell Component]
   928 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "and"

Phrase: "thereby"

Phrase: "becomes"

Phrase: "accessible for translation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0814423:accessibility [Qualitative Concept]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the mSPV/mNAT ratio by quantitative real-time RT-PCR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   754   C1264675:Time ratio [Quantitative Concept]
   754   C1547051:*Time Ratio [Temporal Concept]
   738   C0456603:Ratio [Quantitative Concept]
   738   C1547037:Ratio [Intellectual Product]

Phrase: "in the cytoplasmic fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "of Min6 -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.79: Interestingly, we found an almost 2-fold higher mSPV/mNAT ratio in the cytoplasm (39  3%; P = 0.05; Fig. 4A) compared with cDNA derived from Min6 whole cell extract (22  5%) (11), demonstrating that the mSPV does reach the cytoplasm. 

Phrase: "Interestingly,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "an almost 2-fold higher mSPV/mNAT ratio in the cytoplasm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0456603:Ratio [Quantitative Concept]
   736   C1547037:Ratio [Intellectual Product]

Phrase: "(39  3%"

Phrase: "; P = 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")"

Phrase: "compared with cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C1707455:Compared [Activity]

Phrase: "derived from Min6 whole cell extract"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0007634:Cell [Cell]
   753   C0444667:Whole [Quantitative Concept]
   753   C1269647:Cell [Cell]
   753   C1441547:Derived [Qualitative Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C2828366:Extract [Substance]
   753   C3245521:derived [Idea or Concept]

Phrase: "(22  5%"

Phrase: ")"

Phrase: "(11"

Phrase: ")"

Phrase: ","

Phrase: "demonstrating"

Phrase: "that"

Phrase: "the mSPV"

Phrase: "does"

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "the cytoplasm."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasm [Cell Component]
   928 E C0521449:Cytoplasmic [Body Location or Region]
Processing 00000000.tx.80: Although these findings also suggest that the mSPV may even be transported preferentially out of the nucleus and could thereby enhance insulin translation and synthesis, additional studies are necessary to prove this hypothesis. 

Phrase: "Although"

Phrase: "these findings also"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the mSPV"

Phrase: "may"

Phrase: "even"

Phrase: "be"

Phrase: "transported"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005528:Transport, NOS [Cell Function]
   966   C1317949:Transport [Manufactured Object]
   966   C3495449:transport [Medical Device]

Phrase: "preferentially out of the nucleus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0007610:Nucleus [Cell Component]
   760   C0439787:Out [Spatial Concept]
   760   C0849355:Out [Qualitative Concept]

Phrase: "and"

Phrase: "could"

Phrase: "thereby"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "insulin translation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040712:Translation [Intellectual Product]
   861   C0597295:translation [Molecular Function]
   861   C1519614:Translation [Genetic Function]

Phrase: "and"

Phrase: "synthesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220781:synthesis [Biologic Function]
  1000   C1883254:Synthesis [Activity]

Phrase: "additional studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "necessary to"

Phrase: "prove"

Phrase: "this hypothesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]
Processing 00000000.tx.81: [The overall higher mSPV/mNAT values in these insulinoma-derived Min6 cells compared with normal primary mouse islets are consistent with our previous finding of insulin SPV overexpression in insulinomas (11).] 

Phrase: "["

Phrase: "The overall higher mSPV/mNAT values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0042295:Values [Qualitative Concept]
   766 E C1522609:Value [Quantitative Concept]

Phrase: "in these insulinoma-derived Min6 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "compared with normal primary mouse islets"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C1522528:Mouse Islets [Tissue]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C0205225:Primary [Qualitative Concept]
   753   C0205307:Normal [Qualitative Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C0439631:Primary [Therapeutic or Preventive Procedure]
   753   C1707455:Compared [Activity]
   753   C2347086:% Normal [Quantitative Concept]

Phrase: "are"

Phrase: "consistent with our previous finding of insulin SPV overexpression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332290:Consistent with [Idea or Concept]
           Consistent
   722   C0332529:Consistency finding [Qualitative Concept]

Phrase: "in insulinomas"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021670:Insulinomas [Neoplastic Process]

Phrase: "(11"

Phrase: ")."

Phrase: "]"
Processing 00000000.tx.82: View larger version (12K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(12K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.83: 4. 

Phrase: "4."
Processing 00000000.tx.84: Cytoplasmic Localization and RNA Stability of mSPV A, mSPV expression in cytoplasm. 

Phrase: "Cytoplasmic Localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "RNA Stability of mSPV A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0752249:RNA Stability [Qualitative Concept]
   753   C0205360:Stability [Qualitative Concept]
   753   C2347098:Stability [Qualitative Concept]

Phrase: "mSPV expression in cytoplasm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.85: Total RNA was extracted from Min6 -cells, either straight from whole cell extract (WCE) or from the cytoplasm after cell fractionation (CCE) performed as described in Materials and Methods. 

Phrase: "Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "extracted from Min6 -cells,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C3282337:Cells [Cell]
   770   C3541890:EXTRACTED [Finding]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737 E C2828366:Extract [Substance]

Phrase: "either straight from whole cell extract (WCE)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0445291:Straight [Spatial Concept]

Phrase: "or from the cytoplasm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0010834:Cytoplasm [Cell Component]

Phrase: "after cell fractionation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007593:Cell Fractionation [Laboratory Procedure]
   861   C0016640:fractionation [Laboratory Procedure]
   861   C0524811:fractionation [Therapeutic or Preventive Procedure]
   861   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "(CCE)"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.86: mSPV and mNAT were measured by quantitative real-time RT-PCR. 

Phrase: "mSPV"

Phrase: "and"

Phrase: "mNAT"

Phrase: "were"

Phrase: "measured by quantitative real-time RT-PCR."
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   804   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   804   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   778   C0599161:RT-PCR [Molecular Biology Research Technique]
   778   C1550177:Real Time [Idea or Concept]
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0040223:Time [Temporal Concept]
   748   C0237400:Real [Qualitative Concept]
   748   C0392762:Quantitative [Quantitative Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C0677874:pCR [Finding]
   748   C3272377:REAL [Intellectual Product]
   748   C3541383:Time [Temporal Concept]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.87: Bars represent the mean mSPV/mNAT ratios as a percentage  SEM of triplicate measurements. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the mean mSPV/mNAT ratios as a percentage  SEM"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   739   C0456603:Ratios [Quantitative Concept]
   739   C1610540:*Ratios [Quantitative Concept]
   706 E C1547037:Ratio [Intellectual Product]

Phrase: "of triplicate measurements."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:measurements [Functional Concept]
Processing 00000000.tx.88: B, RNA stability of mNAT and mSPV. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "RNA stability of mNAT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0752249:RNA Stability [Qualitative Concept]
   770   C0205360:Stability [Qualitative Concept]
   770   C2347098:Stability [Qualitative Concept]

Phrase: "and"

Phrase: "mSPV."
Processing 00000000.tx.89: Transcription in Min6 -cells was blocked with actinomycin D (5 g/ml) at 0 h, and the remaining endogenous mNAT () or mSPV RNA (), as a measure of RNA stability, was quantified by real-time RT-PCR using the 18S ribosomal subunit as an internal standard. 

Phrase: "Transcription in Min6 -cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040649:Transcription [Genetic Function]

Phrase: "was"

Phrase: "blocked with actinomycin D"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0010934:Actinomycin D [Amino Acid, Peptide, or Protein,Antibiotic]
   770   C0001259:Actinomycin [Amino Acid, Peptide, or Protein,Antibiotic]
   770   C0028778:Blocked [Pathologic Function]
   770   C0332206:Blocked [Functional Concept]
   770   C2983591:BLOCKED [Research Activity]
   770   C3536807:Actinomycin [Pharmacologic Substance]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "(5 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ml) at 0 h,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0439391:mL/h [Quantitative Concept]
   770   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "the remaining endogenous mNAT"

Phrase: "("

Phrase: ")"

Phrase: "or"

Phrase: "mSPV RNA ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "a measure of RNA stability,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079809:Measure [Quantitative Concept]
   760   C0242485:Measure [Functional Concept]

Phrase: "was"

Phrase: "quantified by real-time RT-PCR"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   820   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   790   C0599161:RT-PCR [Molecular Biology Research Technique]
   790   C1550177:Real Time [Idea or Concept]
   753   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0040223:Time [Temporal Concept]
   753   C0237400:Real [Qualitative Concept]
   753   C0677874:pCR [Finding]
   753   C3272377:REAL [Intellectual Product]
   753   C3541383:Time [Temporal Concept]
   719   C1709793:Quantify [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 18S ribosomal subunit as an internal standard."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1956015:ribosomal subunit [Cell Component]
   744   C1711351:Subunit [Quantitative Concept]
Processing 00000000.tx.90: Bars represent the percentage of remaining RNA after 1 and 24 h of actinomycin D treatment compared with that at 0 h; 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the percentage of remaining RNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "after 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "24 h of actinomycin D treatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]

Phrase: "compared with that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "at 0 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.91: the mean  SEM of at least two independent experiments analyzed in triplicate are shown.  

Phrase: "the mean  SEM of"

Phrase: "at least two independent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "analyzed in triplicate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205174:Triplicate [Quantitative Concept]
   790   C0936012:Analyzed [Research Activity]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.92: RNA Stability of the Insulin SPV To investigate whether increased RNA stability of the SPV was contributing to the increased amount of insulin protein generated, we analyzed the rate of RNA decay of both endogenous mNAT and SPV insulin mRNA using the mouse -cell line, Min6. 

Phrase: "RNA Stability of the Insulin SPV To"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0752249:RNA Stability [Qualitative Concept]
   744   C0205360:Stability [Qualitative Concept]
   744   C2347098:Stability [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "increased RNA stability of the SPV"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0752249:RNA Stability [Qualitative Concept]
   748   C0205360:Stability [Qualitative Concept]
   748   C2347098:Stability [Qualitative Concept]

Phrase: "was"

Phrase: "contributing to the increased amount of insulin protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880177:Contributing [Activity]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: ","

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the rate of RNA decay of both endogenous mNAT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0871208:Rate [Activity]
   742   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "SPV insulin mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the mouse -cell line,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1513528:Mouse Cell Line [Cell]
   901   C0007600:Cell Line [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "Min6."
Processing 00000000.tx.93: Although the mNAT mRNA was found to be quite stable, with 97  7% remaining after 24 h of actinomycin D treatment, the SPV was rapidly degraded, dropping to 43  12% after 1 h and to 30  1% after 24 h (Fig. 4B). 

Phrase: "Although"

Phrase: "the mNAT mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "quite stable,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205360:Stable [Qualitative Concept]
   861   C1547311:Stable [Intellectual Product]

Phrase: "with 97  7% remaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1527428:Remaining [Qualitative Concept]

Phrase: "after 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "of actinomycin D treatment,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0010934:Actinomycin D [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "the SPV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "was"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: ","

Phrase: "dropping to 43  12%"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1705648:Dropping [Activity]
   737 E C1321095:Drop [Quantitative Concept]
   737 E C2347093:Drop [Quantitative Concept]
   737 E C2348338:Drop [Quantitative Concept]

Phrase: "after 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and to 30  1%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "after 24 h (Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.94: These findings make any contribution from RNA stability very unlikely and suggest that the major mechanism leading to more insulin synthesis from the SPV is protein translation. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "any contribution from RNA stability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880177:Contribution [Activity]

Phrase: "very unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750558:Unlikely [Conceptual Entity]
   861   C1710571:Unlikely [Qualitative Concept]

Phrase: "and"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the major mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "leading"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332152:Leading [Temporal Concept]
  1000   C1522538:Leading [Functional Concept]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to more insulin synthesis from the SPV"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0220781:synthesis [Biologic Function]
   744   C1883254:Synthesis [Activity]

Phrase: "is"

Phrase: "protein translation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597295:Protein Translation [Molecular Function]
           translation
   861   C0040712:Translation [Intellectual Product]
   861   C1519614:Translation [Genetic Function]
Processing 00000000.tx.95: Because this increased translation efficiency occurred in wheat germ extract in the absence of any mammalian proteins, involvement of RNA-binding proteins seemed less likely, and cis-acting factors within the 5'UTR sequence of the SPV appeared to be the most plausible mechanism. 

Phrase: "Because"

Phrase: "this increased translation efficiency"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0013682:Efficiency [Quantitative Concept]
   755 E C0442799:Efficient [Qualitative Concept]

Phrase: "occurred in wheat germ extract"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   806   C0452688:Wheatgerm [Food]
   806   C0982459:Wheat Germ [Organic Chemical,Pharmacologic Substance]
   760   C0043137:Wheat [Food]
   760   C0087114:Wheat [Plant]
   760   C1095911:wheat [Pharmacologic Substance]
   760   C1123020:Wheat [Plant]
   760   C1510495:Wheat [Plant]
   760   C1517528:Germ [Idea or Concept]
   760   C1709305:Occurred [Activity]
   760   C2828366:Extract [Substance]
   726 E C2745955:OCCUR [Temporal Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of any mammalian proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "involvement of RNA-binding proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]

Phrase: "seemed"

Phrase: "less likely,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0332148:Likely [Qualitative Concept]
   861   C0439092:less [Intellectual Product]
   861   C0547044:Less [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "and"

Phrase: "cis-acting factors within the 5'UTR sequence"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C1516561:Cis-Acting Sequence [Nucleotide Sequence]
   744   C1504308:Cis [Eukaryote]
   711   C0079613:ACT [Therapeutic or Preventive Procedure]
   711   C1521761:Factor [Functional Concept]
   711   C2827422:Factor [Conceptual Entity]

Phrase: "of the SPV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the most plausible mechanism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.96: Increased Translation Efficiency Is Associated with Alterations In Secondary RNA Structure A potent mechanism of translational regulation by cis-acting factors is based on the secondary RNA structure of the mRNA itself (6, 12). 

Phrase: "Increased Translation Efficiency"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0013682:Efficiency [Quantitative Concept]
   755 E C0442799:Efficient [Qualitative Concept]

Phrase: "Is"

Phrase: "Associated with Alterations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756   C1515926:Alteration [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "In Secondary RNA Structure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0162807:Secondary Structure [Spatial Concept]
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0678594:Structure [Spatial Concept]

Phrase: "A potent mechanism of translational regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "by cis-acting factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1504308:Cis [Eukaryote]
   793   C0079613:ACT [Therapeutic or Preventive Procedure]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "is"

Phrase: "based on the secondary RNA structure of the mRNA"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   762   C0162807:Secondary Structure [Spatial Concept]
   742   C0027627:secondary [Neoplastic Process]
   742   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0175668:Secondary [Temporal Concept]
   742   C0205436:Secondary [Quantitative Concept]
   742   C0678594:Structure [Spatial Concept]
   742   C1527178:Based [Functional Concept]
   742   C1705938:Based [Idea or Concept]
   708 E C0002055:base [Inorganic Chemical]
   708 E C0178499:Base [Chemical Viewed Functionally]
   708 E C1880279:Base [Biomedical or Dental Material]

Phrase: "itself"

Phrase: "(6,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.97: To assess the potential involvement of secondary RNA structure in the observed differences in translation efficiency, we compared the predicted secondary RNA structures of mNAT and mSPV using m-fold. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the potential involvement of secondary RNA structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1314939:Involvement [Functional Concept]

Phrase: "in the observed differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "in translation efficiency,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013682:Efficiency [Quantitative Concept]
   789 E C0442799:Efficient [Qualitative Concept]

Phrase: "we"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "the predicted secondary RNA structures of mNAT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0162807:Secondary Structure [Spatial Concept]
   748   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0678594:structures [Spatial Concept]

Phrase: "and"

Phrase: "mSPV"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "m-"

Phrase: "fold."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332462:Fold [Spatial Concept]
  1000   C1880834:FOLD [Phenomenon or Process]
Processing 00000000.tx.98: We found that retention of intron 1 dramatically altered the structure compared with that of the native RNA (Fig. 5), which was paralleled by the described increase in translation efficiency (Fig. 3). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that retention of intron 1 dramatically"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0035280:Retention [Mental Process]
   753   C0333117:Retention [Functional Concept]
   753   C1753315:retention [Cell Function]

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "the structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "compared with that of the native RNA (Fig. 5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0302891:Native [Functional Concept]
   742   C0349966:Fig [Food]
   742   C1337208:FIG [Food]
   742   C1707455:Compared [Activity]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "was"

Phrase: "paralleled by the described increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0442805:Increase [Functional Concept]
   760   C1552738:described [Idea or Concept]
   726   C2348042:Parallel [Qualitative Concept]
   726   C2826345:PARALLEL [Research Activity]

Phrase: "in translation efficiency"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013682:Efficiency [Quantitative Concept]
   789 E C0442799:Efficient [Qualitative Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.99: View larger version (18K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.100: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.101: Predicted Secondary RNA Structures of mNAT (A) and mSPV (B) 5'UTRs Sequences were analyzed by m-fold as described in Materials and Methods. 

Phrase: "Predicted Secondary RNA Structures of mNAT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0162807:Secondary Structure [Spatial Concept]
   753   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0678594:structures [Spatial Concept]

Phrase: "(A)"

Phrase: "and"

Phrase: "mSPV (B) 5'UTRs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0600680:UTR [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C1420099:UTR [Gene or Genome]
   804   C1540171:UTR [Gene or Genome]

Phrase: "Sequences"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]

Phrase: "were"

Phrase: "analyzed by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0936012:Analyzed [Research Activity]

Phrase: "m-"

Phrase: "fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332462:Fold [Spatial Concept]
  1000   C1880834:FOLD [Phenomenon or Process]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.102: Calculated energies (dG) were 7 for mNAT and 26 for mSPV. 

Phrase: "Calculated energies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0542479:energies [Natural Phenomenon or Process]
   827 E C0424589:Energy [Finding]
   827 E C1442080:Energy [Quantitative Concept]

Phrase: "(dG)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1275573:dg [Quantitative Concept]

Phrase: "were"

Phrase: "7 for mNAT"

Phrase: "and"

Phrase: "26 for mSPV."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
Processing 00000000.tx.103: Open arrows mark the AUG translational start sites. 

Phrase: "Open arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:arrows [Manufactured Object]

Phrase: "mark"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:mark [Qualitative Concept]

Phrase: "the AUG translational start sites."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   812   C0205145:Sites [Spatial Concept]
   812   C0439659:Start [Temporal Concept]
   812   C1519614:Translational [Genetic Function]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]
   741 E C0040712:Translation [Intellectual Product]
   741 E C0597295:translation [Molecular Function]
Processing 00000000.tx.104: Arrowheads point to the sites of the spliced out intron (A) and the beginning and end of the retained intron 1 (B); 

Phrase: "Arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1080898:Arrowheads [Plant]
   966 E C0453107:Arrowhead [Food]

Phrase: "point to the sites of the spliced out intron"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   748   C2945843:Site of [Qualitative Concept]
   742   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0205145:Sites [Spatial Concept]
   742   C0439787:Out [Spatial Concept]
   742   C0849355:Out [Qualitative Concept]
   742   C1552961:Point [Quantitative Concept]
   742   C2347617:point [Quantitative Concept]
   708 E C1515974:Site [Body Location or Region]
   708 E C2825164:Site [Spatial Concept]

Phrase: "(A)"

Phrase: "and"

Phrase: "the beginning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Beginning [Temporal Concept]

Phrase: "and"

Phrase: "end of the retained intron 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0444930:End [Spatial Concept]
   753   C2746065:End [Temporal Concept]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.105: the exonic sequence is shown with bold lines.  

Phrase: "the exonic sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "is"

Phrase: "shown with bold lines."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0205132:lines [Spatial Concept]
   737   C1547282:Show [Intellectual Product]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.106: Expression of the Insulin SPV Is Increased in Diabetes and Insulin Resistance Having identified this insulin mSPV and shown that it exerts increased translation efficiency, we wanted to study its roles in diabetes, obesity, and insulin resistance. 

Phrase: "Expression of the Insulin SPV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "Is"

Phrase: "Increased in Diabetes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "and"

Phrase: "Insulin Resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "Having"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "this insulin mSPV"

Phrase: "and"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "it"

Phrase: "exerts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "increased translation efficiency,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0013682:Efficiency [Quantitative Concept]
   755 E C0442799:Efficient [Qualitative Concept]

Phrase: "we"

Phrase: "wanted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444647:Wanted [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "its roles in diabetes,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0035820:Roles [Social Behavior]
   737 E C1705810:Role [Conceptual Entity]

Phrase: "obesity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "and"

Phrase: "insulin resistance."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.107: We also tested for potential expression of an insulin 1 mSPV (m-1-SPV) retaining intron 1 using specific primers (Table 1), but found only an extremely low expression level, with an m-1-SPV/m-1-NAT ratio of 0.01% even in BTBR ob/ob mice (data not shown); 

Phrase: "We also"

Phrase: "tested for potential expression of an insulin 1 mSPV ("
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   741   C0202098:insulin test [Laboratory Procedure]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0025914:Mouse [Mammal]
   739   C0025929:mouse [Mammal]
   739   C0026809:Mouse [Mammal]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
   739   C0392366:tested [Intellectual Product]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C3245505:Potential [Qualitative Concept]
   706 E C0022885:Test [Laboratory Procedure]
   706 E C0039593:Test [Functional Concept]

Phrase: "m-"

Phrase: "1-SPV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variant [Qualitative Concept]

Phrase: ")"

Phrase: "retaining intron 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0333118:retaining [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "specific primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "an extremely low expression level,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C3244092:expression level [Idea or Concept]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   812   C0441889:Level [Qualitative Concept]
   812   C0456079:Level [Classification]
   812   C1547707:Level [Geographic Area]
   812   C2946261:Level [Pharmacologic Substance]

Phrase: "with an"

Phrase: "m-"

Phrase: "1-SPV/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variant [Qualitative Concept]

Phrase: "m-"

Phrase: "1-NAT ratio of 0.01% even"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0456603:Ratio [Quantitative Concept]
   748   C1547037:Ratio [Intellectual Product]

Phrase: "in BTBR ob/ob mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   886   C1511028:BTBR Mouse [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.108: therefore, we did not further pursue this m-1-SPV. 

Phrase: "therefore,"

Phrase: "we"

Phrase: "did"

Phrase: "not further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1518422:Not [Functional Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "pursue"

Phrase: "this"

Phrase: "m-"

Phrase: "1-SPV."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variant [Qualitative Concept]
Processing 00000000.tx.109: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.110: Oligonucleotides Used in this Study  Focusing on mouse insulin 2, we analyzed mSPV expression in obese (ob/ob) and nonobese (azip) mouse models of diabetes and insulin resistance on different strain backgrounds (BTBR and C57BL/6) (13, 14, 15, 16). 

Phrase: "Oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Used in this Study  Focusing"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   781   C0869040:study use [Research Activity]
   760   C0000936:focusing [Clinical Attribute]
   760   C0557651:Study [Manufactured Object]
   760   C1273517:used [Finding]
   760   C2603343:Study [Research Activity]
   760   C2981153:Focusing [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0205234:Focus [Spatial Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1285542:focus [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "on mouse insulin 2,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0025914:Mouse [Mammal]
   827   C0025929:mouse [Mammal]
   827   C0026809:Mouse [Mammal]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "mSPV expression in obese"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(ob/ob)"

Phrase: "and"

Phrase: "nonobese"

Phrase: "(azip"

Phrase: ")"

Phrase: "mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "models of diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C3161035:Model [Intellectual Product]

Phrase: "and"

Phrase: "insulin resistance on different strain backgrounds"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0021655:Insulin Resistance [Pathologic Function]
   790   C2700570:INSULIN RESISTANCE [Gene or Genome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0237834:Resistance [Mental Process]
   753   C1514892:Resistance [Physiologic Function]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "(BTBR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511028:BTBR [Mammal]

Phrase: "and"

Phrase: "C57BL/6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521751:C57BL/6 [Mammal]
   861   C0025921:C57BL [Mammal]

Phrase: ")"

Phrase: "(13,"

Phrase: "14,"

Phrase: "15,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.111: Using specific primers for mNAT and mSPV, the mSPV/mNAT ratio was determined by quantitative RT-PCR in isolated islets of mutant/transgenic mice and compared with the ratio in wild-type (WT) littermates (Fig. 6). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "specific primers for mNAT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "mSPV,"

Phrase: "the mSPV/mNAT ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "determined by quantitative RT-PCR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   806   C0599161:RT-PCR [Molecular Biology Research Technique]
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0392762:Quantitative [Quantitative Concept]
   760   C0677874:pCR [Finding]

Phrase: "in isolated islets"

Phrase: "of mutant/transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mice, Transgenic [Mammal]
   827   C0003069:Transgenic [Animal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "compared with the ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0456603:Ratio [Quantitative Concept]
   770   C1547037:Ratio [Intellectual Product]
   770   C1707455:Compared [Activity]

Phrase: "in wild-type (WT) littermates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.112: The mean mSPV/mNAT ratio in WT mice was 4.9  0.7% (Table 2). 

Phrase: "The mean mSPV/mNAT ratio in WT mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0456603:Ratio [Quantitative Concept]
   739   C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "4.9  0.7%"

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.113: (In contrast to the other control mice, the C57BL/6 azip controls were all females, which may explain the higher mSPV/mNAT ratio observed.) 

Phrase: "("

Phrase: "In contrast to the"

Phrase: "other control mice,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "the C57BL/6 azip controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0243148:control [Qualitative Concept]
   779   C1550141:Control [Substance]
   779   C1882979:Control [Conceptual Entity]
   779   C2587213:Control [Functional Concept]
   779   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "all females,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0015780:Females [Finding]
  1000   C0086287:Females [Population Group]
   966 E C0043210:female [Population Group]
   966 E C1705497:Female [Qualitative Concept]
   966 E C1705498:Female [Qualitative Concept]

Phrase: "which"

Phrase: "may"

Phrase: "explain"

Phrase: "the higher mSPV/mNAT ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0456603:Ratio [Quantitative Concept]
   804   C1547037:Ratio [Intellectual Product]

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ")"
Processing 00000000.tx.114: Interestingly, the mSPV/mNAT ratio was 3.7-fold elevated in diabetic BTBR ob/ob animals compared with lean WT controls (Fig. 6A). 

Phrase: "Interestingly,"

Phrase: "the mSPV/mNAT ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "3.7-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "elevated in diabetic BTBR ob/ob animals"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0003062:Animals [Animal]
   748   C0205250:Elevated [Qualitative Concept]
   748   C0241863:DIABETIC [Finding]
   748   C1511028:BTBR [Mammal]
   748   C3163633:Elevated [Qualitative Concept]

Phrase: "compared with lean WT controls"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C1883559:Wild Type [Organism Attribute]
   767   C1707504:Control Type [Research Activity]
   767   C1879930:Control Type [Intellectual Product]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
   753   C1707455:Compared [Activity]
   719   C0243148:control [Qualitative Concept]
   719   C1550141:Control [Substance]
   719   C1882979:Control [Conceptual Entity]
   719   C2587213:Control [Functional Concept]
   719   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.115: In the insulin-resistant, nondiabetic, C57BL/6 ob/ob and C57BL/6 azip mice significantly higher mSPV/mNAT values were found compared with healthy controls (Fig. 6, B and C). 

Phrase: "In the insulin-resistant, nondiabetic, C57BL/6 ob/ob"

Phrase: "and"

Phrase: "C57BL/6 azip mice significantly higher mSPV/mNAT values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0042295:Values [Qualitative Concept]
   756 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "compared with healthy controls"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   816   C2986479:Healthy Control [Qualitative Concept]
   770   C1707455:Compared [Activity]
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.116: View larger version (10K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(10K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.117: 6. 

Phrase: "6."
Processing 00000000.tx.118: mSPV Overexpression in Diabetic and Insulin-Resistant Mice The mSPV, expressed as the mSPV to mNAT ratio, was measured by quantitative real-time RT-PCR in islets from A) obese, insulin-resistant, and diabetic BTBR ob/ob mice; 

Phrase: "mSPV Overexpression in Diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "and"

Phrase: "Insulin-Resistant Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "The mSPV,"

Phrase: "expressed as the mSPV"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]

Phrase: "to mNAT ratio,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "measured by quantitative real-time RT-PCR"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   804   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   804   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   778   C0599161:RT-PCR [Molecular Biology Research Technique]
   778   C1550177:Real Time [Idea or Concept]
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0040223:Time [Temporal Concept]
   748   C0237400:Real [Qualitative Concept]
   748   C0392762:Quantitative [Quantitative Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C0677874:pCR [Finding]
   748   C3272377:REAL [Intellectual Product]
   748   C3541383:Time [Temporal Concept]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]

Phrase: "in islets"

Phrase: "from A) obese, insulin-resistant,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332325:Resistant [Functional Concept]
   812   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "and"

Phrase: "diabetic BTBR ob/ob mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C1511028:BTBR Mouse [Mammal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: ";"
Processing 00000000.tx.119: B) obese and insulin-resistant C57BL/6 ob/ob mice; 

Phrase: "B) obese"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028754:Obese [Disease or Syndrome]

Phrase: "and"

Phrase: "insulin-resistant C57BL/6 ob/ob mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0025921:Mice, C57BL [Mammal]
   857   C1521751:C57BL/6 Mouse [Mammal]
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: ";"
Processing 00000000.tx.120: and C) nonobese, lipoatrophic, insulin-resistant C57BL/6 azip mice as described in Materials and Methods. 

Phrase: "and"

Phrase: "C) nonobese, lipoatrophic, insulin-resistant C57BL/6 azip mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   829   C0025921:Mice, C57BL [Mammal]
   822   C1521751:C57BL/6 Mouse [Mammal]
   791   C0025914:Mice [Mammal]
   791   C0025929:mice [Mammal]
   791   C0026809:Mice [Mammal]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.121: Bars represent the fold change in the mSPV/mNAT ratio in transgenic mice compared with WT controls set at 1. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the fold change in the mSPV/mNAT ratio"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C1880833:Fold Change [Quantitative Concept]
   762   C0025320:The change [Physiologic Function]
   742   C0392747:Change [Functional Concept]
   742   C0443172:change [Quantitative Concept]
   742   C1705241:Change [Quantitative Concept]

Phrase: "in transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "compared with WT controls"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C1883559:Wild Type [Organism Attribute]
   781   C1707504:Control Type [Research Activity]
   781   C1879930:Control Type [Intellectual Product]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1707455:Compared [Activity]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "at 1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]
Processing 00000000.tx.122: Data are presented as the mean  SEM of triplicate determinations.  

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "presented as the mean  SEM of triplicate determinations."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   744   C0205174:Triplicate [Quantitative Concept]
   744   C0444504:Mean [Quantitative Concept]
   744   C0449450:Presented [Idea or Concept]
   744   C0680730:determinations [Governmental or Regulatory Activity]
   744   C2347634:Mean [Quantitative Concept]
   744   C2348143:Mean [Quantitative Concept]
   711 E C0150312:Present [Quantitative Concept]
   711 E C1148554:determination [Laboratory Procedure]
Processing 00000000.tx.123: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.124: mSPV/mNAT Ratios in the Three Mouse Models Studied (Absolute Numbers)  These results suggest that although hyperglycemia is clearly contributing to mSPV overexpression, insulin resistance in the presence and absence of obesity also causes an increase in mSPV expression. 

Phrase: "mSPV/mNAT Ratios in the Three Mouse Models"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   742   C0456603:Ratios [Quantitative Concept]
   742   C1610540:*Ratios [Quantitative Concept]
   708 E C1547037:Ratio [Intellectual Product]

Phrase: "Studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "(Absolute Numbers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: ")"

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "although"

Phrase: "hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "is"

Phrase: "clearly"

Phrase: "contributing to mSPV overexpression,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C1514559:Overexpression [Genetic Function]
   760   C1880177:Contributing [Activity]

Phrase: "insulin resistance in the presence"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0021655:Insulin Resistance [Pathologic Function]
   806   C2700570:INSULIN RESISTANCE [Gene or Genome]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0237834:Resistance [Mental Process]
   760   C1514892:Resistance [Physiologic Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "absence of obesity also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "an increase in mSPV expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]
Processing 00000000.tx.125: Interestingly, despite some differences in the absolute mSPV/mNAT ratios in the different mouse models, overall insulin-resistant transgenic or mutant animals had a significantly higher mSPV/mNAT ratio than WT mice, as assessed by two-way ANOVA (Table 2). 

Phrase: "Interestingly,"

Phrase: "despite some differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "in the absolute mSPV/mNAT ratios"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0456603:Ratios [Quantitative Concept]
   804   C1610540:*Ratios [Quantitative Concept]
   771 E C1547037:Ratio [Intellectual Product]

Phrase: "in the different mouse models,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C2986594:Mouse Model [Experimental Model of Disease]
   827   C3161035:Models [Intellectual Product]

Phrase: "overall insulin-resistant transgenic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003069:Transgenic [Animal]

Phrase: "or"

Phrase: "mutant animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "had"

Phrase: "a significantly higher mSPV/mNAT ratio than WT mice,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0456603:Ratio [Quantitative Concept]
   738   C1547037:Ratio [Intellectual Product]

Phrase: "as"

Phrase: "assessed by two-way ANOVA (Table 2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C1710497:Two-way ANOVA [Quantitative Concept]
   748   C0039224:Table [Manufactured Object]
   748   C0205448:Two [Quantitative Concept]
   748   C1516048:Assessed [Activity]
   748   C1706073:Table [Medical Device]
   748   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.126: Glucose Is Sufficient to Increase mSPV Expression in Primary Mouse Islets To address the question of whether glucose alone could induce mSPV expression outside the context of any additional factors present in insulin-resistant or diabetic animals, we measured mSPV/mNAT ratios in primary mouse islets isolated from lean WT mice. 

Phrase: "Glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "Is"

Phrase: "Sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "Increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "mSPV Expression in Primary Mouse Islets To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "the question of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1522634:Question [Intellectual Product]

Phrase: "whether"

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "could"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "mSPV expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "outside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205101:Outside [Spatial Concept]

Phrase: "the context of any additional factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449255:Context [Finding]
   753   C0542559:Context [Functional Concept]

Phrase: "present in insulin-resistant"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0150312:Present [Quantitative Concept]
   770   C0332325:Resistant [Functional Concept]
   770   C0449450:Present [Idea or Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C2827757:RESISTANT [Laboratory or Test Result]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "or"

Phrase: "diabetic animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "mSPV/mNAT ratios in primary mouse islets"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0456603:Ratios [Quantitative Concept]
   744   C1610540:*Ratios [Quantitative Concept]
   711 E C1547037:Ratio [Intellectual Product]

Phrase: "isolated from lean WT mice."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   799   C1520150:Wild Type Mouse [Mammal]
   790   C1883559:Wild Type [Organism Attribute]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0205409:Isolated [Functional Concept]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
   753   C1548221:Isolated [Idea or Concept]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.127: Incubation of these islets at high glucose for 70 h led to a dramatic 15-fold increase in the mSPV/mNAT ratio (Fig. 7), suggesting that glucose is sufficient to induce mSPV expression in healthy mouse islets. 

Phrase: "Incubation of these islets"

Phrase: "at high glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0860803:high glucose [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "for 70 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "led to a dramatic 15-fold increase"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   748   C0332462:Fold [Spatial Concept]
   748   C0442805:Increase [Functional Concept]
   748   C1708698:LED [Manufactured Object]
   748   C1880834:FOLD [Phenomenon or Process]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C1522538:Lead [Functional Concept]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the mSPV/mNAT ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "is"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "mSPV expression in healthy mouse islets."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.128: View larger version (15K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.129: 7. 

Phrase: "7."
Processing 00000000.tx.130: Glucose Induction of mSPV in Primary Mouse Islets Islets were isolated from six WT C57BL/6 mice and incubated at low (2.5 mM) or high (25 mM) glucose for 70 h before total RNA was extracted. 

Phrase: "Glucose Induction of mSPV"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "in Primary Mouse Islets Islets"

Phrase: "were"

Phrase: "isolated from six WT C57BL/6 mice"
Meta Candidates (Total=18; Excluded=2; Pruned=0; Remaining=16)
   789   C1521751:C57BL/6 Mouse [Mammal]
           C57BL/6
   776   C1520150:Wild Type Mouse [Mammal]
   770   C1883559:Wild Type [Organism Attribute]
   767   C0025921:Mice, C57BL [Mammal]
           C57BL
   767   C1960442:Type 6 [Intellectual Product]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0205409:Isolated [Functional Concept]
   744   C0205452:Six [Quantitative Concept]
   744   C0332307:Type [Qualitative Concept]
   744   C0445392:Wild [Intellectual Product]
   744   C1547052:*Type [Quantitative Concept]
   744   C1548221:Isolated [Idea or Concept]
   711 E C0370215:Isolate [Substance]
   711 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "incubated at low"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205251:low [Qualitative Concept]
   790   C1299352:Low [Qualitative Concept]
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1550472:low [Idea or Concept]

Phrase: "(2.5 mM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0450346:2 5 [Quantitative Concept]

Phrase: "or"

Phrase: "high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205250:High [Qualitative Concept]
  1000   C1299351:High [Qualitative Concept]
  1000   C2700149:HIGH [Intellectual Product]

Phrase: "(25 mM) glucose for 70 h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "before total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "extracted."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]
Processing 00000000.tx.131: The expression of mNAT and mSPV was measured by quantitative real-time RT-PCR. 

Phrase: "The expression of mNAT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "mSPV"

Phrase: "was"

Phrase: "measured by quantitative real-time RT-PCR."
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   804   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   804   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   778   C0599161:RT-PCR [Molecular Biology Research Technique]
   778   C1550177:Real Time [Idea or Concept]
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0040223:Time [Temporal Concept]
   748   C0237400:Real [Qualitative Concept]
   748   C0392762:Quantitative [Quantitative Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C0677874:pCR [Finding]
   748   C3272377:REAL [Intellectual Product]
   748   C3541383:Time [Temporal Concept]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.132: Bars represent mSPV/mNAT ratios (mean  SEM of triplicate determinations) at low () and high () glucose concentrations.   

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "mSPV/mNAT ratios"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0456603:Ratios [Quantitative Concept]
   812   C1610540:*Ratios [Quantitative Concept]
   779 E C1547037:Ratio [Intellectual Product]

Phrase: "(mean  SEM of triplicate determinations"

Phrase: ")"

Phrase: "at low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "("

Phrase: ")"

Phrase: "and"

Phrase: "high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205250:High [Qualitative Concept]
  1000   C1299351:High [Qualitative Concept]
  1000   C2700149:HIGH [Intellectual Product]

Phrase: "("

Phrase: ")"

Phrase: "glucose concentrations."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0427743:Glucose concentration [Laboratory Procedure]
   983   C1287281:Glucose concentration [Laboratory or Test Result]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.133: DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  In the present study we demonstrate that islets of diabetic and insulin-resistant mice overexpress an insulin gene SPV that can be translated more efficiently into normal (prepro)insulin protein. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES  In the present study"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C2985663:Study Reference [Intellectual Product]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1514811:Reference [Idea or Concept]
   760   C1706462:Reference [Conceptual Entity]
   760   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "demonstrate"

Phrase: "that islets of diabetic"

Phrase: "and"

Phrase: "insulin-resistant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "overexpress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:overexpress [Genetic Function]

Phrase: "an insulin gene SPV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205419:Variant [Qualitative Concept]

Phrase: "that"

Phrase: "can"

Phrase: "be"

Phrase: "translated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040710:translated [Occupational Activity]

Phrase: "more efficiently into normal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205172:More [Functional Concept]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C2347086:% Normal [Quantitative Concept]

Phrase: "(prepro)insulin protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.134: Interestingly, we previously showed that normal human islets also express a similar insulin gene SPV conferring increased translation efficiency (10). 

Phrase: "Interestingly,"

Phrase: "we previously"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that normal human islets also"

Phrase: "express"

Phrase: "a similar insulin gene SPV conferring increased translation efficiency"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   791   C0013682:Efficiency [Quantitative Concept]
   720 E C0442799:Efficient [Qualitative Concept]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.135: Although we found that the expression of this human SPV was up-regulated by glucose in a time-dependent manner (10), its pathophysiological significance under conditions of altered glucose homeostasis remained unknown. 

Phrase: "Although"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the expression of this human SPV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "up-regulated by glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0547043:Up [Spatial Concept]
   770   C0851285:Regulated [Governmental or Regulatory Activity]
   770   C1282911:Up [Spatial Concept]

Phrase: "in a time-dependent manner"

Phrase: "(10"

Phrase: ")"

Phrase: ","

Phrase: "its pathophysiological significance under conditions of altered glucose homeostasis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0237881:Significance [Quantitative Concept]
   742   C0750502:Significance [Idea or Concept]

Phrase: "remained"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.136: We therefore used the mSPV described here to gain insight into the role of this newly identified phenomenon of alternative splicing of the insulin gene in diabetes, obesity, and insulin resistance. 

Phrase: "We therefore"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the mSPV"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "here to"

Phrase: "gain"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1517378:Gain [Quantitative Concept]
   944 E C0205217:Increased [Quantitative Concept]
   944 E C0439661:Acquired [Temporal Concept]
   944 E C0442805:Increase [Functional Concept]
   944 E C0442808:Increasing [Functional Concept]
   944 E C1301820:Obtain [Functional Concept]
   944 E C1706701:Acquire [Activity]
   944 E C3245488:acquired [Intellectual Product]

Phrase: "insight into the role of this newly identified phenomenon of alternative splicing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0233820:Insight [Mental Process]

Phrase: "of the insulin gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1337112:Insulin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "in diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "obesity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "and"

Phrase: "insulin resistance."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.137: The importance of alternative RNA processing in the endocrine system has recently began to emerge (17), and the fact that alternative splicing of the insulin gene is conserved between species suggests that it plays an important physiological role. 

Phrase: "The importance of alternative RNA processing"

Phrase: "in the endocrine system"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0014136:Endocrine system [Body System]
           Endocrine
  1000   C0559306:ENDOCRINE SYSTEM [Finding]
  1000   C1280975:Endocrine system [Body System]
   861   C0449913:System [Functional Concept]
   861   C0521425:Endocrine [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "has"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "began"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Begin [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "emerge"

Phrase: "(17"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the fact"

Phrase: "that alternative splicing of the insulin gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0002345:Alternative Splicing [Genetic Function]
   774   C0017365:gene splicing [Gene or Genome]
   774   C0017387:Gene Splicing [Molecular Biology Research Technique]
   748   C0035687:Splicing [Genetic Function]
   748   C2610186:splicing [Genetic Function]

Phrase: "is"

Phrase: "conserved between species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1705920:Species [Conceptual Entity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "it"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an important physiological role."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035820:Role [Social Behavior]
   827   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.138: Human and mouse insulin SPVs differ, in that in humans only the first 26 bp of intron 1 are retained, whereas the 5'UTR of the mSPV includes the whole intron 1 (Fig. 1). 

Phrase: "Human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "and"

Phrase: "mouse insulin SPVs"

Phrase: "differ"

Phrase: ","

Phrase: "in that"

Phrase: "in humans only"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086418:Humans [Human]

Phrase: "the first 26 bp of intron 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   774   C2984182:BP-1 [Gene or Genome]

Phrase: "are"

Phrase: "retained"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retained [Functional Concept]

Phrase: ","

Phrase: "whereas"

Phrase: "the 5'UTR of the mSPV"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0600680:UTR [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C1420099:UTR [Gene or Genome]
   748   C1540171:UTR [Gene or Genome]

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the whole intron 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0444667:Whole [Quantitative Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.139: The first question was therefore whether this mSPV retaining all 102 bp of intron 1 would also confer increased translation efficiency in analogy to the human SPV (10). 

Phrase: "The first question"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1522634:Question [Intellectual Product]

Phrase: "was"

Phrase: "therefore"

Phrase: "whether"

Phrase: "this mSPV retaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333118:retaining [Functional Concept]

Phrase: "all 102 bp of intron 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   783   C2984182:BP-1 [Gene or Genome]

Phrase: "would"

Phrase: "also"

Phrase: "confer"

Phrase: "increased translation efficiency in analogy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0013682:Efficiency [Quantitative Concept]

Phrase: "to the human SPV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variant [Qualitative Concept]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.140: We found high levels of mSPV in the cytoplasm of -cells (Fig. 4A), confirming that the mSPV does not represent pre-mRNA trapped in the nucleus and suggesting that it contributes to insulin translation in vivo. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "high levels of mSPV"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the cytoplasm of -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the mSPV"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "pre-mRNA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0026661:Pre-mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0035695:Pre-mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0332152:Pre [Temporal Concept]
   861   C0740175:Pre [Qualitative Concept]
   861   C2257086:PRE [Genetic Function]

Phrase: "trapped in the nucleus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0007610:Nucleus [Cell Component]
   770   C0184047:Trapped [Medical Device]

Phrase: "and"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "it"

Phrase: "contributes to insulin translation"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0040712:Translation [Intellectual Product]
   770   C0597295:translation [Molecular Function]
   770   C1519614:Translation [Genetic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1880177:Contribute [Activity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.141: Furthermore, our in vitro translation assays demonstrate that compared with mNAT mRNA, the mSPV is translated more efficiently into normal mouse (prepro)insulin (Fig. 3, A and B). 

Phrase: "Furthermore,"

Phrase: "our in vitro translation assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   906   C1515653:In Vitro Assay [Research Activity]
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "compared with mNAT mRNA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1707455:Compared [Activity]

Phrase: "the mSPV"

Phrase: "is"

Phrase: "translated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040710:translated [Occupational Activity]

Phrase: "more efficiently into normal mouse"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C0205172:More [Functional Concept]
   760   C0205307:Normal [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C2347086:% Normal [Quantitative Concept]

Phrase: "(prepro)insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.142: In addition, we show that the mSPV 5'UTR confers increased translation efficiency to a heterologous reporter gene in in vivo transfection studies (Fig. 3C). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the mSPV 5'UTR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0600680:UTR [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1420099:UTR [Gene or Genome]
   812   C1540171:UTR [Gene or Genome]

Phrase: "confers"

Phrase: "increased translation efficiency to a heterologous reporter gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0013682:Efficiency [Quantitative Concept]

Phrase: "in in vivo transfection studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   906   C0681829:in vivo study [Research Activity]
   812   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.143: This suggests that the species difference lies solely at the sequence level and that functionally, in terms of increased translation efficiency, the two insulin SPVs are the same. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the species difference"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0178849:species difference [Biologic Function]
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "lies"

Phrase: "solely at the sequence level"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1519249:Sequence [Functional Concept]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "that functionally,"

Phrase: "in terms of increased translation efficiency,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0013682:Efficiency [Quantitative Concept]
   755 E C0442799:Efficient [Qualitative Concept]

Phrase: "the two insulin SPVs"

Phrase: "are"

Phrase: "the same."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445247:Same [Qualitative Concept]
Processing 00000000.tx.144: Moreover, we found that translation efficiency correlated with changes in the predicted secondary RNA structure of the 5'UTRs (Fig. 5). 

Phrase: "Moreover,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that translation efficiency"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013682:Efficiency [Quantitative Concept]
   789 E C0442799:Efficient [Qualitative Concept]

Phrase: "correlated with changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   790   C1707520:Correlated [Qualitative Concept]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in the predicted secondary RNA structure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0162807:Secondary Structure [Spatial Concept]
   812   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0678594:Structure [Spatial Concept]

Phrase: "of the 5'UTRs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0600493:5' UTR [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0600680:UTR [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1420099:UTR [Gene or Genome]
   861   C1540171:UTR [Gene or Genome]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.145: This is again consistent with our findings in human islets (10) and studies of RNA structure affecting translation in other systems (6, 12) as well as with the hypothesis that the altered RNA structure may facilitate ribosomal binding and thereby enhance translation. 

Phrase: "This"

Phrase: "is"

Phrase: "again consistent with our findings"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent
   745   C0332529:Consistency finding [Qualitative Concept]

Phrase: "in human islets"

Phrase: "(10"

Phrase: ")"

Phrase: "and"

Phrase: "studies of RNA structure affecting translation"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   783   C0678935:RNA translation [Genetic Function]
   753   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0040712:Translation [Intellectual Product]
   753   C0392760:Affecting [Functional Concept]
   753   C0557651:Study [Manufactured Object]
   753   C0597295:translation [Molecular Function]
   753   C0678594:Structure [Spatial Concept]
   753   C0947630:studies [Laboratory Procedure]
   753   C1314939:Affecting [Functional Concept]
   753   C1519614:Translation [Genetic Function]
   753   C2603343:Study [Research Activity]

Phrase: "in other systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0449913:System [Functional Concept]
   966   C1553451:System [Manufactured Object]
   966   C1704459:System [Medical Device]
   916 E C0205373:Systemic [Functional Concept]

Phrase: "(6,"

Phrase: "12"

Phrase: ")"

Phrase: "as well as with the hypothesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205170:Well [Qualitative Concept]
   753   C1512571:Hypothesis [Idea or Concept]
   753   C3146287:Well [Manufactured Object]

Phrase: "that"

Phrase: "the altered RNA structure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0678594:Structure [Spatial Concept]

Phrase: "may"

Phrase: "facilitate"

Phrase: "ribosomal binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   964   C1323391:ribosome binding [Molecular Function]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "thereby"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "translation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040712:Translation [Intellectual Product]
  1000   C0597295:translation [Molecular Function]
  1000   C1519614:Translation [Genetic Function]
Processing 00000000.tx.146: The discovery of this mSPV functioning similar to that of the human SPV provided a model to investigate the role of the insulin SPV in diabetes, obesity, and insulin resistance. 

Phrase: "The discovery of this mSPV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880355:Discovery [Activity]

Phrase: "functioning"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0542341:functioning [Functional Concept]
   966 E C0031843:function [Physiologic Function]
   966 E C0700205:FUNCTION [Classification]
   966 E C1705273:Function [Intellectual Product]

Phrase: "similar to that of the human SPV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2348205:Similar [Qualitative Concept]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "a model to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the role of the insulin SPV"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "obesity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "and"

Phrase: "insulin resistance."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.147: Human studies are limited, because diabetic or insulin-resistant organ donors are typically excluded, and their islets are not isolated. 

Phrase: "Human studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0178693:human studies [Research Activity]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "limited"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0439801:Limited [Functional Concept]
  1000   C3542948:Limited [Intellectual Product]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]

Phrase: ","

Phrase: "because"

Phrase: "diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "or"

Phrase: "insulin-resistant organ donors"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0029206:Organ Donors [Population Group]
   844 E C1548659:Organ donor [Idea or Concept]
   844 E C1716004:Organ donor [Clinical Attribute]
   812   C0013018:Donors [Population Group]
   812   C1527169:Donors [Finding]
   779 E C0040288:Donor [Population Group]

Phrase: "are"

Phrase: "typically"

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "their islets"

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "isolated."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.148: In addition, severe confounding effects from premortem diabetes treatment and from the lengthy process of human islet isolation have to be expected if such islets are to be analyzed. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "severe confounding effects from premortem diabetes treatment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   757   C1518681:Treatment Effect [Finding]
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "and from the lengthy process of human islet isolation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0086418:Human [Human]
   742   C0204727:Isolation [Therapeutic or Preventive Procedure]
   742   C0205409:Isolation [Functional Concept]
   742   C0220862:isolation [Laboratory Procedure]
   742   C1184743:Process [Body Part, Organ, or Organ Component]
   742   C1515981:And [Idea or Concept]
   742   C1522240:Process [Phenomenon or Process]

Phrase: "have"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "if"

Phrase: "such islets"

Phrase: "are"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "analyzed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.149: To avoid these problems, we used three different mouse models to study the expression of the mSPV and now demonstrate that mSPV is significantly overexpressed in diabetes (BTBR ob/ob; Fig. 6A) and insulin resistance (C57BL/6 ob/ob; Fig. 6B) of obese mice as well as in nonobese, insulin-resistant mice (C57BL/6 azip; Fig. 6C). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "avoid"

Phrase: "these problems,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1546466:Problems [Idea or Concept]
   966 E C0033213:Problem [Finding]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "three different mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mouse [Mammal]
   827   C0025929:mouse [Mammal]
   827   C0026809:Mouse [Mammal]

Phrase: "models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the expression of the mSPV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "demonstrate"

Phrase: "that mSPV"

Phrase: "is"

Phrase: "significantly"

Phrase: "overexpressed in diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   756   C1514559:overexpress [Genetic Function]

Phrase: "(BTBR ob/ob"

Phrase: "; Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")"

Phrase: "and"

Phrase: "insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(C57BL/6 ob/ob"

Phrase: "; Fig. 6B"

Phrase: ")"

Phrase: "of obese mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0025933:Mice, Obese [Mammal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "as well as in nonobese, insulin-resistant mice"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0205170:Well [Qualitative Concept]
   744   C0332325:Resistant [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C2827757:RESISTANT [Laboratory or Test Result]
   744   C3146287:Well [Manufactured Object]

Phrase: "(C57BL/6 azip"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1521751:C57BL/6 [Mammal]

Phrase: "; Fig. 6C"

Phrase: ")."
Processing 00000000.tx.150: In addition to these single comparisons within each mouse model (Fig. 6) and despite some variability in absolute mSPV/mNAT numbers between them, taking all mouse models together revealed that overall, insulin-resistant mice have a significantly higher mSPV/mNAT ratio than WT controls (Table 2). 

Phrase: "In addition to these single comparisons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707455:Comparison [Activity]

Phrase: "within each mouse model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2986594:Mouse Model [Experimental Model of Disease]
   861   C3161035:Model [Intellectual Product]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "and despite some variability"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1515981:And [Idea or Concept]
   770   C2827666:Variability [Conceptual Entity]

Phrase: "in absolute mSPV/mNAT numbers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0237753:*Number [Quantitative Concept]
   804   C0449788:Number [Quantitative Concept]

Phrase: "between them,"

Phrase: "taking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515187:Take [Health Care Activity]

Phrase: "all mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that overall,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282416:Overall [Intellectual Product]
  1000   C1561607:Overall [Qualitative Concept]

Phrase: "insulin-resistant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "have"

Phrase: "a significantly higher mSPV/mNAT ratio than WT controls"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0456603:Ratio [Quantitative Concept]
   738   C1547037:Ratio [Intellectual Product]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.151: Because alternative splicing allows for more insulin biosynthesis (via increased translation efficiency of the mSPV) without the need for more transcription of the insulin gene, it is tempting to speculate that mSPV expression may represent a compensatory mechanism of the -cell at times of increased insulin requirements, such as hyperglycemia and/or insulin resistance. 

Phrase: "Because"

Phrase: "alternative splicing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002345:Alternative Splicing [Genetic Function]
   861   C0035687:Splicing [Genetic Function]
   861   C2610186:splicing [Genetic Function]

Phrase: "allows for more insulin biosynthesis"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0005572:biosynthesis [Functional Concept]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0220781:Biosynthesis [Biologic Function]
   760   C0683607:allow [Social Behavior]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "("

Phrase: "via increased translation efficiency"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0013682:Efficiency [Quantitative Concept]
   755 E C0442799:Efficient [Qualitative Concept]

Phrase: "of the mSPV)"

Phrase: "without the need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "for more transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040649:Transcription [Genetic Function]

Phrase: "of the insulin gene,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1337112:Insulin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "it"

Phrase: "is"

Phrase: "tempting"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "speculate"

Phrase: "that mSPV expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a compensatory mechanism of the -cell"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "at times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:times [Temporal Concept]
  1000   C1632851:Times [Quantitative Concept]
   966 E C3541383:Time [Temporal Concept]
   928 E C0442043:Temporal [Spatial Concept]
   928 E C2362314:Temporal [Temporal Concept]

Phrase: "of increased insulin requirements,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   896   C0520917:Increased requirement [Pathologic Function]
   793   C1514873:Requirement [Functional Concept]
   734   C0020459:increased insulin [Disease or Syndrome]

Phrase: "such as hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "and/or"

Phrase: "insulin resistance."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.152: Because there are currently no tools available to artificially overexpress the mSPV in vivo without otherwise altering the metabolism, we are unable to assess at this point whether mSPV expression is truly able to improve insulin production and glucose homeostasis in insulin-resistant or diabetic animals, and the compensatory mechanism discussed remains hypothetical. 

Phrase: "Because"

Phrase: "there"

Phrase: "are"

Phrase: "currently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521116:Currently [Temporal Concept]

Phrase: "no tools available to artificially"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0470187:Available [Functional Concept]
   779   C0336791:Tool [Manufactured Object]
   779   C2827396:Tool [Manufactured Object]

Phrase: "overexpress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:overexpress [Genetic Function]

Phrase: "the mSPV"

Phrase: "in vivo without otherwise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "altering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   907   C0392747:Altered [Functional Concept]

Phrase: "the metabolism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "we"

Phrase: "are"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "assess at this point"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1516048:Assess [Activity]
   770   C1552961:Point [Quantitative Concept]
   770   C2347617:point [Quantitative Concept]

Phrase: "whether"

Phrase: "mSPV expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "truly able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]

Phrase: "improve"

Phrase: "insulin production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "glucose homeostasis in insulin-resistant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1326961:glucose homeostasis [Physiologic Function]
   760   C0019868:Homeostasis [Biologic Function]

Phrase: "or"

Phrase: "diabetic animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "and"

Phrase: "the compensatory mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "discussed"

Phrase: "remains"

Phrase: "hypothetical."
Processing 00000000.tx.153: It also remains to be determined whether mSPV overexpression is reversible and whether it occurs in other forms of obesity, insulin resistance, or diabetes. 

Phrase: "It also"

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "determined"

Phrase: "whether"

Phrase: "mSPV overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514559:Overexpression [Genetic Function]

Phrase: "is"

Phrase: "reversible"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205343:Reversible [Functional Concept]
   928 E C0449261:Reversibility [Temporal Concept]

Phrase: "and"

Phrase: "whether"

Phrase: "it"

Phrase: "occurs in other forms of obesity,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0028754:Obesity [Disease or Syndrome]
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   753   C1709305:Occur [Activity]
   753   C1963185:Obesity [Finding]
   753   C2745955:OCCUR [Temporal Concept]
   719 E C1522492:Form [Functional Concept]

Phrase: "insulin resistance,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.154: Nevertheless, to date our findings establish that -cells of three distinct diabetic/insulin-resistant mouse models respond with increased mSPV expression. 

Phrase: "Nevertheless,"

Phrase: "to date"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "that -cells of three distinct diabetic/insulin-resistant mouse models"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   764   C1522214:Mouse Insulin Cell [Cell]
   741   C0030281:Insulin Cell [Cell]
   739   C0007634:Cells [Cell]
   739   C3282337:Cells [Cell]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "respond with increased mSPV expression."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
Processing 00000000.tx.155: Although we cannot rule out the possibility that the genetic background or the leptin deficiency present in both ob/ob and azip mice may have contributed to the observed effects, our findings of induced SPV expression in isolated primary mouse islets incubated at high glucose concentration (Fig. 7) suggest that such factors are not required. 

Phrase: "Although"

Phrase: "we"

Phrase: "cannot"

Phrase: "rule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0805874:Rule [Idea or Concept]
  1000   C0870077:Rule [Intellectual Product]
  1000   C1446409:rule [Qualitative Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "the possibility"

Phrase: "that"

Phrase: "the genetic background"
Meta Candidates (Total=17; Excluded=14; Pruned=0; Remaining=3)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   861   C1706907:Background [Conceptual Entity]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "or"

Phrase: "the leptin deficiency present in both ob/ob"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0150312:Present [Quantitative Concept]
   744   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "azip mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "may"

Phrase: "have"

Phrase: "contributed to the observed effects,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C1280500:effects [Qualitative Concept]
   760   C1441672:Observed [Functional Concept]
   726   C1880177:Contribute [Activity]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "our findings of induced SPV expression"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   748   C2607943:findings [Functional Concept]
   748   C2926606:Findings [Clinical Attribute]
   748   C3539655:Findings [Intellectual Product]
   714 E C0037088:Finding [Sign or Symptom]
   714 E C0243095:Finding [Finding]
   714 E C2825141:Finding [Finding]

Phrase: "in isolated primary mouse islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1522528:Mouse Islets [Tissue]

Phrase: "incubated at high glucose concentration"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0427743:Glucose concentration [Laboratory Procedure]
   806   C0860803:high glucose [Finding]
   806   C1287281:Glucose concentration [Laboratory or Test Result]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0086045:Concentration [Mental Process]
   760   C0205250:High [Qualitative Concept]
   760   C1299351:High [Qualitative Concept]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1446561:Concentration [Quantitative Concept]
   760   C2700149:HIGH [Intellectual Product]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "such factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "required."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]
Processing 00000000.tx.156: Instead, these findings imply that elevated glucose levels are sufficient to induce SPV expression, which is consistent with our previous observation of increased human SPV in response to glucose (10). 

Phrase: "Instead,"

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "imply"

Phrase: "that elevated glucose levels"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "SPV expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "which"

Phrase: "is"

Phrase: "consistent with our previous observation of increased human SPV"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.157: In contrast, insulin did not affect SPV expression in human islets (10), making hyperinsulinemia or an autocrine insulin effect very unlikely as the cause of increased mSPV expression in insulin-resistant mice. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "SPV expression in human islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(10"

Phrase: ")"

Phrase: ","

Phrase: "making"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "hyperinsulinemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "or"

Phrase: "an autocrine insulin effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]

Phrase: "very unlikely as the cause of increased mSPV expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0750558:Unlikely [Conceptual Entity]
   739   C1710571:Unlikely [Qualitative Concept]

Phrase: "in insulin-resistant mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.158: To investigate the possibility that increased RNA stability of the mSPV may be involved in some of the observed findings, we measured the RNA decay of endogenous mouse mNAT and mSPV and found that mSPV RNA is degraded faster than mNAT (30% vs. 97% remaining after 24 h, respectively; Fig. 4B). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the possibility"

Phrase: "that increased RNA stability of the mSPV"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0752249:RNA Stability [Qualitative Concept]
   744   C0205360:Stability [Qualitative Concept]
   744   C2347098:Stability [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "involved in some of the observed findings,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   748   C1314939:Involved [Functional Concept]
   748   C1441672:Observed [Functional Concept]
   748   C2607943:findings [Functional Concept]
   748   C2926606:Findings [Clinical Attribute]
   748   C3539655:Findings [Intellectual Product]
   714 E C0037088:Finding [Sign or Symptom]
   714 E C0243095:Finding [Finding]
   714 E C2825141:Finding [Finding]

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the RNA decay of endogenous mouse mNAT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1257755:RNA Decay [Molecular Function]
   748   C1265875:Decay [Acquired Abnormality]
   748   C2700592:Decay [Phenomenon or Process]

Phrase: "and"

Phrase: "mSPV"

Phrase: "and"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that mSPV RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "faster than mNAT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0015663:Fast [Finding]
   756   C0456962:Fast [Qualitative Concept]

Phrase: "(30%"

Phrase: "vs. 97% remaining after 24 h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1527428:Remaining [Qualitative Concept]

Phrase: "respectively"

Phrase: "; Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.159: Therefore, the increased amount of (prepro)insulin protein generated from mSPV seems to be due to increased translation efficiency and not to increased mSPV RNA stability. 

Phrase: "Therefore,"

Phrase: "the increased amount of (prepro)insulin protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   709   C0020459:increased insulin [Disease or Syndrome]

Phrase: "generated from mSPV"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   770   C3146294:Generated [Activity]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be due to increased translation efficiency"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0678226:Due to [Functional Concept]
           due
   753   C0013682:Efficiency [Quantitative Concept]
   753   C0040712:Translation [Intellectual Product]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0597295:translation [Molecular Function]
   753   C1519614:Translation [Genetic Function]
   753   C2987476:Be [Conceptual Entity]
   753   C3146286:Due [Idea or Concept]

Phrase: "and"

Phrase: "not to increased mSPV RNA stability."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0752249:RNA Stability [Qualitative Concept]
   748   C0025914:Mouse [Mammal]
   748   C0025929:mouse [Mammal]
   748   C0026809:Mouse [Mammal]
   748   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0205217:Increased [Quantitative Concept]
   748   C0205360:Stability [Qualitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C1518422:Not [Functional Concept]
   748   C2347098:Stability [Qualitative Concept]
Processing 00000000.tx.160: In fact, due to the rapid mSPV RNA degradation within 1 h (43% remaining), we may have underestimated the effect of mSPV on translation efficiency in our translation assays. 

Phrase: "In fact,"

Phrase: "due to the rapid mSPV RNA degradation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C1257756:RNA Degradation [Genetic Function]
   840   C2984321:RNA degradation [Functional Concept]
   804   C0243125:degradation [Functional Concept]
   804   C0699900:Degradation [Organism Function]

Phrase: "within 1 h (43% remaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1527428:Remaining [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "may"

Phrase: "have"

Phrase: "underestimated"

Phrase: "the effect of mSPV"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on translation efficiency"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013682:Efficiency [Quantitative Concept]
   789 E C0442799:Efficient [Qualitative Concept]

Phrase: "in our translation assays."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.161: The reduced RNA stability of mSPV compared with mNAT also suggests that the observed increase in mSPV expression in diabetic and insulin-resistant mice (Fig. 6) results from enhanced alternative splicing of the insulin gene rather than selectively decreased degradation of mSPV RNA. 

Phrase: "The reduced RNA stability of mSPV"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0752249:RNA Stability [Qualitative Concept]
   748   C0205360:Stability [Qualitative Concept]
   748   C2347098:Stability [Qualitative Concept]

Phrase: "compared with mNAT also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Compared [Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the observed increase in mSPV expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "in diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "insulin-resistant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "results from enhanced alternative splicing of the insulin gene"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   764   C0002345:Alternative Splicing [Genetic Function]
   764   C1337112:Insulin Gene [Gene or Genome]
   762   C0017365:gene splicing [Gene or Genome]
   762   C0017387:Gene Splicing [Molecular Biology Research Technique]
   742   C0017337:Gene [Gene or Genome]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0035687:Splicing [Genetic Function]
   742   C1274040:Result [Functional Concept]
   742   C1523987:Alternative [Conceptual Entity]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1546471:Result [Idea or Concept]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C2349975:Enhanced [Activity]
   742   C2610186:splicing [Genetic Function]
   742   C2825142:Result [Finding]

Phrase: "rather than"

Phrase: "selectively decreased degradation of mSPV RNA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1257756:RNA Degradation [Genetic Function]
   774   C2984321:RNA degradation [Functional Concept]
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]
Processing 00000000.tx.162: Because the diabetes/insulin resistance of the studied mice is genetically determined, and no acute intervention was performed to induce mSPV expression in these animals, it seems reasonable to assume that the mSPV/mNAT measurements obtained take the relative mSPV instability into account and reflect a steady state. 

Phrase: "Because"

Phrase: "the diabetes/insulin resistance of the studied mice"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   800   C0342335:diabetes insulin resistance [Disease or Syndrome]
   770   C0021655:Insulin Resistance [Pathologic Function]
   770   C2700570:INSULIN RESISTANCE [Gene or Genome]
   769 E C0854110:Insulin resistant diabetes [Disease or Syndrome]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0237834:Resistance [Mental Process]
   744   C1514892:Resistance [Physiologic Function]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]

Phrase: "is"

Phrase: "genetically"

Phrase: "determined"

Phrase: ","

Phrase: "and"

Phrase: "no acute intervention"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0886296:intervention [Health Care Activity]
   861   C1273869:Intervention [Health Care Activity]
   861   C1948041:Intervention [Therapeutic or Preventive Procedure]
   789 E C3274035:INTERVENTIONAL [Research Activity]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "mSPV expression in these animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "it"

Phrase: "seems"

Phrase: "reasonable to"

Phrase: "assume"

Phrase: "that"

Phrase: "the mSPV/mNAT measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0242485:measurements [Functional Concept]

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "take"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "the relative mSPV instability into account"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1444783:Instability [Finding]

Phrase: "and"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "a steady state."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0678587:steady state [Natural Phenomenon or Process]
   861   C0205361:Steady [Qualitative Concept]
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]
Processing 00000000.tx.163: Taken together, the results of these studies suggest a novel mechanism by which alternative splicing of the 5'UTR leads to enhanced translation and protein synthesis in response to in vivo changes in glucose homeostasis. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "the results of these studies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0683954:results studies [Finding]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a novel mechanism by which alternative splicing of the 5'UTR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0441712:Mechanism [Functional Concept]
   738   C1706376:Mechanism [Manufactured Object]

Phrase: "leads to enhanced translation"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0040712:Translation [Intellectual Product]
   770   C0181586:leads [Medical Device]
   770   C0597295:translation [Molecular Function]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1519614:Translation [Genetic Function]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C2349975:Enhanced [Activity]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "protein synthesis in response"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0597295:Protein Synthesis [Molecular Function]
   783 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0220781:synthesis [Biologic Function]
   770   C1883254:Synthesis [Activity]

Phrase: "to in vivo changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0392747:changes [Functional Concept]
   827   C0443172:changes [Quantitative Concept]
   793 E C1705241:Change [Quantitative Concept]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "in glucose homeostasis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1326961:glucose homeostasis [Physiologic Function]
   861   C0019868:Homeostasis [Biologic Function]
Processing 00000000.tx.164: This pathway confers metabolic control of protein synthesis without the need for increased transcription and thereby represents a powerful biological mechanism that may also regulate the production of other proteins. 

Phrase: "This pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathway [Molecular Function]
  1000   C1705987:Pathway [Conceptual Entity]

Phrase: "confers"

Phrase: "metabolic control of protein synthesis"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C1513158:Metabolic Control [Molecular Function]
   760   C0243148:control [Qualitative Concept]
   760   C0311400:Metabolic [Functional Concept]
   760   C1524026:Metabolic [Cell Function]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2707259:Metabolic [Clinical Attribute]
   760   C3274648:Control [Qualitative Concept]

Phrase: "without the need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "for increased transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040649:Transcription [Genetic Function]

Phrase: "and"

Phrase: "thereby"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a powerful biological mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "may"

Phrase: "also"

Phrase: "regulate"

Phrase: "the production of other proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]
Processing 00000000.tx.165: However, if not actively sought, it can easily remain unappreciated, because it involves only subtle changes in the noncoding region of the target gene. 

Phrase: "However,"

Phrase: "if"

Phrase: "not actively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "sought"

Phrase: ","

Phrase: "it"

Phrase: "can"

Phrase: "easily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332219:Easily [Qualitative Concept]

Phrase: "remain"

Phrase: "unappreciated,"

Phrase: "because"

Phrase: "it"

Phrase: "involves"

Phrase: "only subtle changes in the noncoding region of the target gene."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   738   C0392747:changes [Functional Concept]
   738   C0443172:changes [Quantitative Concept]
   704 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.166: Even more importantly, our findings of mSPV overexpression in diabetic and insulin-resistant mice conferring increased insulin translation provide new insight into the regulation of insulin biosynthesis as well as into -cell biology in the face of insulin resistance and diabetes. 

Phrase: "Even more importantly,"

Phrase: "our findings of mSPV overexpression"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C2607943:findings [Functional Concept]
   753   C2926606:Findings [Clinical Attribute]
   753   C3539655:Findings [Intellectual Product]
   719 E C0037088:Finding [Sign or Symptom]
   719 E C0243095:Finding [Finding]
   719 E C2825141:Finding [Finding]

Phrase: "in diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "insulin-resistant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "conferring"

Phrase: "increased insulin translation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0040712:Translation [Intellectual Product]
   827   C0597295:translation [Molecular Function]
   827   C1519614:Translation [Genetic Function]
   734   C0020459:increased insulin [Disease or Syndrome]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "new insight into the regulation of insulin biosynthesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0233820:Insight [Mental Process]

Phrase: "as well as into -cell biology"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   753   C0005532:Biology [Biomedical Occupation or Discipline]
   753   C0007634:Cell [Cell]
   753   C0205170:Well [Qualitative Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C3146287:Well [Manufactured Object]

Phrase: "in the face"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015450:Face [Body Location or Region]
  1000   C1281591:Face [Body Part, Organ, or Organ Component]

Phrase: "of insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.167: Increased -cell mass through replication and neogenesis has been known as the main compensatory mechanism of the -cell in response to insulin resistance (18, 19, 20). 

Phrase: "Increased -"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "cell mass through replication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0577559:Mass [Finding]
   770   C1306372:*Mass [Quantitative Concept]
   770   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "neogenesis"

Phrase: "has"

Phrase: "been"

Phrase: "known as the main compensatory mechanism of the -cell"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   742   C0007634:Cell [Cell]
   742   C0205225:Main [Qualitative Concept]
   742   C0205309:Known [Qualitative Concept]
   742   C0231186:Compensatory [Functional Concept]
   742   C0441712:Mechanism [Functional Concept]
   742   C1269647:Cell [Cell]
   742   C1542147:Main [Qualitative Concept]
   742   C1704653:Cell [Medical Device]
   742   C1706376:Mechanism [Manufactured Object]
   742   C1948049:Cell [Spatial Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(18,"

Phrase: "19,"

Phrase: "20"

Phrase: ")."
Processing 00000000.tx.168: Defects in this pathway and loss of functional -cell mass by apoptosis are thought to underlie the progression to overt diabetes (20, 21, 22). 

Phrase: "Defects in this pathway"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0243067:defects [Functional Concept]
   737 E C1457869:Defect [Functional Concept]
   737 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "and"

Phrase: "loss of functional -cell mass"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "by apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "are"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "underlie"

Phrase: "the progression to overt diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0242656:progression [Pathologic Function]
   760   C0449258:Progression [Functional Concept]

Phrase: "(20,"

Phrase: "21,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.169: These and other findings have made the importance of the -cell in the development of type 2 diabetes more apparent over the last years (23, 24, 25). 

Phrase: "These"

Phrase: "and"

Phrase: "other findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "have"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "the importance of the -cell"

Phrase: "in the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "more apparent over the last years"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0750489:apparent [Idea or Concept]

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.170: However, regulatory steps of insulin synthesis and compensatory mechanisms within the -cell have remained largely unknown, and a better understanding of the processes involved is critical to improve diabetes treatment and identify novel therapeutic targets. 

Phrase: "However,"

Phrase: "regulatory steps of insulin synthesis"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C1261552:steps [Conceptual Entity]
   726 E C1704379:Step [Functional Concept]
   726 E C1705117:Step [Quantitative Concept]
   726 E C2825408:Step [Manufactured Object]

Phrase: "and"

Phrase: "compensatory mechanisms within the -cell"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]

Phrase: "have"

Phrase: "remained"

Phrase: "largely unknown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439673:Unknown [Qualitative Concept]

Phrase: "and"

Phrase: "a better understanding of the processes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0162340:Understanding [Mental Process]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "is"

Phrase: "critical to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511545:Critical [Qualitative Concept]

Phrase: "improve"

Phrase: "diabetes treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "and"

Phrase: "identify"

Phrase: "novel therapeutic targets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1521840:Target [Functional Concept]
   793   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.171: The results presented here shed new light on these aspects as they raise the possibility that overexpression of the newly identified insulin SPV may represent an attempt of the -cell to maintain adequate insulin biosynthesis (a prerequisite of insulin secretion) when insulin requirements are increased by obesity, insulin resistance, and diabetes.  

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here"

Phrase: "shed"

Phrase: "new light on these aspects"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0023693:Light [Natural Phenomenon or Process]
   760   C1306462:Light [Functional Concept]
   760   C1881376:Light [Qualitative Concept]

Phrase: "as"

Phrase: "they"

Phrase: "raise"

Phrase: "the possibility"

Phrase: "that overexpression of the newly identified insulin SPV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1514559:Overexpression [Genetic Function]

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "an attempt of the -cell to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1516084:Attempt [Event]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "adequate insulin biosynthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0005572:biosynthesis [Functional Concept]
   827   C0220781:Biosynthesis [Biologic Function]

Phrase: "("

Phrase: "a prerequisite of insulin secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0679209:prerequisite [Idea or Concept]

Phrase: ")"

Phrase: "when"

Phrase: "insulin requirements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514873:Requirement [Functional Concept]

Phrase: "are"

Phrase: "increased by obesity,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0028754:Obesity [Disease or Syndrome]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C1963185:Obesity [Finding]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "insulin resistance,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.172: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Cloning of the mSPV and Plasmid Construction Pancreatic RNA was extracted from healthy BL/6 mice (gift from Dr. Klaus Pechhold, NIDDK, NIH) and reverse transcribed with the First Strand cDNA synthesis kit (Roche, Indianapolis, IN). 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cloning of the mSPV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "Plasmid Construction Pancreatic RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "extracted from healthy BL/6 mice"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0006413:BL [Neoplastic Process]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0185115:Extracted [Therapeutic or Preventive Procedure]
   753   C1552663:BL [Idea or Concept]
   753   C2827109:BL [Geographic Area]
   753   C3541890:EXTRACTED [Finding]
   719 E C2828366:Extract [Substance]

Phrase: "(gift from Dr. Klaus Pechhold,"

Phrase: "NIDDK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1513898:NIDDK [Health Care Related Organization]

Phrase: "NIH)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027468:NIH [Health Care Related Organization]

Phrase: "and"

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "transcribed with the First Strand cDNA synthesis kit (Roche,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   742   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0205435:First [Quantitative Concept]
   742   C0220781:synthesis [Biologic Function]
   742   C0331965:Roche [Health Care Related Organization]
   742   C0812225:KIT [Medical Device]
   742   C1150635:KIT [Molecular Function]
   742   C1279901:First [Qualitative Concept]
   742   C1704972:Strand [Spatial Concept]
   742   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C1705212:Kit [Medical Device]
   742   C1705213:KIT [Medical Device]
   742   C1883254:Synthesis [Activity]
   742   C3273202:Kit [Manufactured Object]

Phrase: "Indianapolis,"

Phrase: "IN"

Phrase: ")."
Processing 00000000.tx.173: A standard 35-cycle PCR was performed with the Elongase kit (Invitrogen Life Technologies, Inc., Carlsbad CA) using specific primers 1 and 3 for mNAT and primers 2 and 3 for mSPV (Table 1). 

Phrase: "A standard 35-cycle PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0677874:pCR [Finding]

Phrase: "was"

Phrase: "performed with the Elongase kit (Invitrogen Life Technologies,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   744   C0039421:technologies [Occupation or Discipline]
   744   C0376558:Life [Idea or Concept]
   744   C0812225:KIT [Medical Device]
   744   C0884358:Performed [Functional Concept]
   744   C1150635:KIT [Molecular Function]
   744   C1705212:Kit [Medical Device]
   744   C1705213:KIT [Medical Device]
   744   C3273202:Kit [Manufactured Object]
   711 E C2947996:Perform [Pharmacologic Substance]

Phrase: "Inc.,"

Phrase: "Carlsbad"

Phrase: "CA)"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "specific primers 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205369:Specific [Qualitative Concept]
   827   C1552740:specific [Intellectual Product]
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "3 for mNAT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439086:<3 [Quantitative Concept]
   790   C2827736:3+ [Quantitative Concept]
   790   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "primers 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "3 for mSPV (Table 1"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C0039224:Table [Manufactured Object]
   753   C0439086:<3 [Quantitative Concept]
   753   C1706073:Table [Medical Device]
   753   C1706074:Table [Intellectual Product]
   753   C2827736:3+ [Quantitative Concept]
   753   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.174: The mSPV and mNAT PCR products, including the 5'UTR from position 38 with and without the 102 bp of intron 1, respectively, were cloned into the pcDNA3.1/V5-His-TOPO vector (Invitrogen Life Technologies, Inc.) under the control of the T7 promoter. 

Phrase: "The mSPV"

Phrase: "and"

Phrase: "mNAT PCR products,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the 5'UTR from position 38"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0600680:UTR [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C1420099:UTR [Gene or Genome]
   753   C1540171:UTR [Gene or Genome]

Phrase: "with"

Phrase: "and without the 102 bp of intron 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C2984182:BP-1 [Gene or Genome]
   744   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C1515981:And [Idea or Concept]

Phrase: "respectively,"

Phrase: "were"

Phrase: "cloned into the pcDNA3.1/V5-"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0009013:cloned [Cell]
   753   C2349105:V5+ [Element, Ion, or Isotope]
   719 E C1522642:Clone [Tissue]

Phrase: "His-TOPO vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "(Invitrogen Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc.) under the control of the T7 promoter."
Processing 00000000.tx.175: To generate reporter constructs, the mouse insulin 5'UTR was amplified from Min6 cDNA using the Elongase kit and primers 13 and 15 for the mNAT 5'UTR and primers 14 and 15 for the mSPV. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "reporter constructs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "the mouse insulin 5'UTR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0600680:UTR [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1420099:UTR [Gene or Genome]
   812   C1540171:UTR [Gene or Genome]

Phrase: "was"

Phrase: "amplified from Min6 cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Elongase kit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0812225:KIT [Medical Device]
   861   C1150635:KIT [Molecular Function]
   861   C1705212:Kit [Medical Device]
   861   C1705213:KIT [Medical Device]
   861   C3273202:Kit [Manufactured Object]

Phrase: "and"

Phrase: "primers 13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "15 for the mNAT 5'UTR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0600680:UTR [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C1420099:UTR [Gene or Genome]
   753   C1540171:UTR [Gene or Genome]

Phrase: "and"

Phrase: "primers 14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "15 for the mSPV."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
Processing 00000000.tx.176: Primers contained the HindIII restriction sites, and PCR-generated amplicons were ligated into the HindIII site of the pGL3 control vector (Promega Corp., Madison, WI) between the simian virus 40 promoter and the firefly luciferase reporter gene. 

Phrase: "Primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "the HindIII restriction sites,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   867   C1882940:Restriction Site [Nucleotide Sequence]
   827   C0205145:Sites [Spatial Concept]
   827   C0443288:Restriction [Functional Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "PCR-generated amplicons"

Phrase: "were"

Phrase: "ligated into the HindIII site of the pGL3 control vector"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   760   C0031249:control vector [Occupational Activity]
   760   C2945843:Site of [Qualitative Concept]
   739   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0205145:Site [Spatial Concept]
   739   C0243148:control [Qualitative Concept]
   739   C0442335:Vector [Spatial Concept]
   739   C1515974:Site [Body Location or Region]
   739   C1550141:Control [Substance]
   739   C1705099:Vector [Idea or Concept]
   739   C1854336:PGL3 [Disease or Syndrome]
   739   C1882979:Control [Conceptual Entity]
   739   C2587213:Control [Functional Concept]
   739   C2825164:Site [Spatial Concept]
   739   C3273620:PGL3 [Gene or Genome]
   739   C3274648:Control [Qualitative Concept]

Phrase: "(Promega Corp.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corp. [Organization]

Phrase: "Madison,"

Phrase: "WI) between the simian virus 40 promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0043193:WI [Geographic Area]

Phrase: "and"

Phrase: "the firefly luciferase reporter gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C1334435:Luciferase Gene [Gene or Genome]
   861   C0206414:Reporter Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.177: All constructs were confirmed by sequencing. 

Phrase: "All constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "confirmed by sequencing."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0750484:Confirmed [Idea or Concept]
   790   C1553778:Sequencing [Intellectual Product]
   790   C1561491:Sequencing [Functional Concept]
   756 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.178: Northern Blotting Total RNA was isolated from Min6 -cells and 293 cells using TRIzol (Invitrogen Life Technologies, Inc.) according to the manufacturers instructions and run on a denaturing agarose gel containing 2% formaldehyde and 1x 4-morpholinepropanesulfonic acid. 

Phrase: "Northern Blotting Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "isolated from Min6 -cells"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C0370215:Isolate [Substance]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "293 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "TRIzol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0916178:trizol [Organic Chemical]

Phrase: "(Invitrogen Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc.) according to the manufacturers instructions"

Phrase: "and"

Phrase: "run on"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0035953:run [Daily or Recreational Activity]
   861   C0600140:run [Finding]
   861   C1704688:Run [Functional Concept]
   861   C2346414:Run [Finding]

Phrase: "a denaturing agarose gel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1706746:Agarose Gel [Research Device]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C1382104:Gel [Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "2% formaldehyde"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "1x 4-morpholinepropanesulfonic acid."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.179: RNA was transferred to a nylon membrane in 10x standard saline citrate overnight and cross-linked to the membrane. 

Phrase: "RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "transferred to a nylon membrane"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0025255:Membrane [Tissue]
   760   C0028736:Nylon [Biomedical or Dental Material,Organic Chemical]
   760   C0348011:transferred [Functional Concept]
   760   C0596901:Membrane [Cell Component]
   760   C0740034:Nylon [Biomedical or Dental Material]
   760   C1706182:Membrane [Manufactured Object]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]

Phrase: "in 10x standard saline citrate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0008857:Citrate [Organic Chemical]
   812   C0036082:Saline [Substance]
   812   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
   812   C1442989:Standard [Qualitative Concept]
   812   C2828392:Standard [Intellectual Product]

Phrase: "overnight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]

Phrase: "and"

Phrase: "cross-linked to the membrane."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0178576:Cross Linked [Natural Phenomenon or Process]
   806   C0332220:cross linked [Functional Concept]
   760   C0025255:Membrane [Tissue]
   760   C0596901:Membrane [Cell Component]
   760   C1706182:Membrane [Manufactured Object]
   760   C2828360:Cross [Conceptual Entity]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
Processing 00000000.tx.180: Probes were generated by PCR using primers 9 and 10 for mNAT and primers 11 and 12 for mSPV. 

Phrase: "Probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0182400:Probes [Medical Device]
   966 E C1704681:Probe [Gene or Genome]
   966 E C2347609:Probe [Chemical Viewed Functionally]
   966 E C3536729:Probe [Manufactured Object]

Phrase: "were"

Phrase: "generated by PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]
   790   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers 9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "10 for mNAT"

Phrase: "and"

Phrase: "primers 11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "12 for mSPV."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
Processing 00000000.tx.181: Products were purified by gel extraction and labeled with Redivue P-32 (Amersham Biosciences, Piscataway, NJ) using the Rediprime II Random Prime Labeling system (Amersham Biosciences). 

Phrase: "Products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "purified by gel extraction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0017243:Gel [Biomedical or Dental Material]
   770   C0185115:Extraction [Therapeutic or Preventive Procedure]
   770   C0684295:extraction [Laboratory Procedure]
   770   C1382104:Gel [Substance]
   770   C1998793:Purified [Functional Concept]

Phrase: "and"

Phrase: "labeled with Redivue P-32"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   797   C0851287:32-P [Element, Ion, or Isotope,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C1708632:Labeled [Qualitative Concept]
   726 E C0181496:Label [Manufactured Object]
   726 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(Amersham Biosciences,"

Phrase: "Piscataway,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551491:Piscataway [Population Group]

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Rediprime II Random Prime Labeling system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0449913:System [Functional Concept]
   799   C1553451:System [Manufactured Object]
   799   C1704459:System [Medical Device]
   727 E C0205373:Systemic [Functional Concept]

Phrase: "(Amersham Biosciences"

Phrase: ")."
Processing 00000000.tx.182: Membranes were incubated with the probes overnight at 65 C in a rotating incubator. 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "incubated with the probes overnight"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0182400:Probes [Medical Device]
   760   C0439583:Overnight [Temporal Concept]
   760   C1439852:Incubated [Laboratory Procedure]
   726 E C1704681:Probe [Gene or Genome]
   726 E C2347609:Probe [Chemical Viewed Functionally]
   726 E C3536729:Probe [Manufactured Object]

Phrase: "at 65 C in"

Phrase: "a rotating incubator."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021178:Incubator [Manufactured Object]
Processing 00000000.tx.183: After washing three times with decreasing concentrations of SCC (2x to 0.1x) with 0.1% sodium dodecyl sulfate, bands were visualized by radiography using BioMax light film (Eastman Kodak Co., Rochester, NY) and a 2-h exposure at 80 C. 

Phrase: "After"

Phrase: "washing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "three times with decreasing concentrations of SCC (2x"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0040223:times [Temporal Concept]
   744   C1632851:Times [Quantitative Concept]
   711 E C3541383:Time [Temporal Concept]

Phrase: "to 0.1x"

Phrase: ")"

Phrase: "with 0.1% sodium dodecyl sulfate,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   884   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   853   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   840   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   804   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   804   C0038720:Sulfate [Inorganic Chemical]
   804   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   804   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   804   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "visualized by radiography"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0034571:radiography [Functional Concept]
   790   C0043299:radiography [Diagnostic Procedure]
   790   C0234621:Visualized [Functional Concept]
   790   C1962945:Radiography [Diagnostic Procedure]
   718 E C0444708:Radiographic [Natural Phenomenon or Process]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "BioMax light film"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086296:Film [Manufactured Object]
   827   C1561571:film [Biomedical or Dental Material]
   827   C1561572:film [Substance]

Phrase: "(Eastman Kodak Co.,"

Phrase: "Rochester,"

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "a 2-h exposure at 80 C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0274281:Exposure, NOS [Injury or Poisoning]
   748   C0332157:Exposure [Clinical Attribute]
Processing 00000000.tx.184: In Vitro Translation Assays Plasmid DNA was linearized with the restriction enzyme StuI and transcribed using the RiboMAX large-scale RNA production system according to the manufacturers instructions (Promega Corp.). 

Phrase: "In Vitro Translation Assays Plasmid DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "linearized with the restriction enzyme StuI"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0012906:Restriction Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0443288:Restriction [Functional Concept]

Phrase: "and"

Phrase: "transcribed"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the RiboMAX large-scale RNA production system according to the manufacturers instructions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0449913:System [Functional Concept]
   736   C1553451:System [Manufactured Object]
   736   C1704459:System [Medical Device]

Phrase: "(Promega Corp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corp. [Organization]

Phrase: ")."
Processing 00000000.tx.185: Transcribed RNA was deoxyribonucleased and purified, and 1.5 g uncapped RNA were added to a 12.5-l in vitro translation reaction using the TNT wheat germ extract system (Promega Corp.) and 35S-labeled methionine (Amersham Biosciences). 

Phrase: "Transcribed RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "deoxyribonucleased"

Phrase: "and"

Phrase: "purified,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "and"

Phrase: "1.5 g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439267:g% [Quantitative Concept]
   734   C0450316:1/5 [Quantitative Concept]

Phrase: "uncapped"

Phrase: "RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "added to a 12.5-l in vitro translation reaction"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   760   C0021135:In Vitro [Intellectual Product]
   760   C1533691:in vitro [Qualitative Concept]
           vitro
   760   C2827718:In Vitro [Functional Concept]
   739   C0040712:Translation [Intellectual Product]
   739   C0443286:Reaction [Functional Concept]
   739   C0597295:translation [Molecular Function]
   739   C1114821:Reaction [Clinical Attribute]
   739   C1519614:Translation [Genetic Function]
   739   C1524062:Added [Functional Concept]
   706 E C1883712:Add [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the TNT wheat germ extract system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0449913:System [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   733 E C0205373:Systemic [Functional Concept]

Phrase: "(Promega Corp.)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corp. [Organization]

Phrase: "and"

Phrase: "35S-labeled methionine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(Amersham Biosciences"

Phrase: ")."
Processing 00000000.tx.186: Due to the absence of a ubiquitination system, the wheat germ extract is superior to the reticulocyte lysate system for the production of small proteins such as insulin. 

Phrase: "Due to the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of a ubiquitination system,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "the wheat germ extract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C2828366:Extract [Substance]
   734   C0452688:Wheatgerm [Food]
   734   C0982459:Wheat Germ [Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "superior to the reticulocyte lysate system"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1282910:Superior [Spatial Concept]

Phrase: "for the production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "of small proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "such as insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.187: Samples were run on a 1020% Tris-glycine gel, the in vitro translated 35S-labeled preproinsulin was visualized by radiography, and the amount of translated protein was quantified with ImageQuant 5.2 (Amersham Biosciences). 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "run on"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0035953:run [Daily or Recreational Activity]
   861   C0600140:run [Finding]
   861   C1704688:Run [Functional Concept]
   861   C2346414:Run [Finding]

Phrase: "a 1020% Tris-glycine gel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0017243:Gel [Biomedical or Dental Material]
   812   C1382104:Gel [Substance]

Phrase: "the in vitro translated 35S-labeled preproinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0071928:Proinsulin, pre- [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "visualized by radiography,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0034571:radiography [Functional Concept]
   790   C0043299:radiography [Diagnostic Procedure]
   790   C0234621:Visualized [Functional Concept]
   790   C1962945:Radiography [Diagnostic Procedure]
   718 E C0444708:Radiographic [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "the amount of translated protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "quantified with ImageQuant 5.2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1709793:Quantify [Quantitative Concept]

Phrase: "(Amersham Biosciences"

Phrase: ")."
Processing 00000000.tx.188: Transfection Studies 293 Cells were plated in 12-well plates, grown overnight to 60% confluence, and transfected with the reporter constructs containing the 5'UTR of mNAT or mSPV (0.5 g DNA/well) using FuGene 6 (Roche) according to the manufacturers instructions. 

Phrase: "Transfection Studies 293 Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated in 12-well"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205170:Well [Qualitative Concept]
   770   C3146287:Well [Manufactured Object]
   737   C0005971:Plate [Medical Device]
   737   C1139930:plate [Medical Device]
   737   C3537155:Plate [Manufactured Object]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: ","

Phrase: "grown overnight to 60% confluence,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439583:Overnight [Temporal Concept]

Phrase: "and"

Phrase: "transfected with the reporter constructs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0335038:Reporter [Professional or Occupational Group]
   760   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   760   C1705915:Reporter [Conceptual Entity]
   760   C1709908:Reporter [Group]
   726   C2827421:Construct [Classification]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the 5'UTR of mNAT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0600680:UTR [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1420099:UTR [Gene or Genome]
   760   C1540171:UTR [Gene or Genome]

Phrase: "or"

Phrase: "mSPV (0.5 g DNA/well"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   818   C0444499:0/5 [Quantitative Concept]
   795   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0025914:Mouse [Mammal]
   795   C0025929:mouse [Mammal]
   795   C0026809:Mouse [Mammal]
   795   C0205170:Well [Qualitative Concept]
   795   C0439267:g% [Quantitative Concept]
   795   C3146287:Well [Manufactured Object]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "FuGene 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0916399:FuGene 6 [Lipid]
           FuGene

Phrase: "(Roche"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331965:Roche [Health Care Related Organization]

Phrase: ")"

Phrase: "according to the manufacturers instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.189: To control for transfection efficiency, cells were cotransfected with 5 ng/well pRL-thymidine kinase (Promega Corp.) control plasmid expressing the Renilla luciferase reporter gene. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "control for transfection efficiency,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0013682:Efficiency [Quantitative Concept]
   770   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cotransfected with 5 ng/well pRL-thymidine kinase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0040078:Thymidine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C2347325:ng/well [Quantitative Concept]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0040077:Thymidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0205170:Well [Qualitative Concept]
   744   C3146287:Well [Manufactured Object]

Phrase: "(Promega Corp.)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corp. [Organization]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "expressing"

Phrase: "the Renilla luciferase reporter gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C1334435:Luciferase Gene [Gene or Genome]
   861   C0206414:Reporter Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.190: Three hours after transfection, medium was changed to DMEM containing 25 mM glucose, 10% fetal bovine serum, and 1% penicillin-streptomycin. 

Phrase: "Three hours after transfection,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0439227:hours [Temporal Concept]
   737 E C0564385:/hour [Quantitative Concept]

Phrase: "medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "changed to DMEM"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0392747:Changed [Functional Concept]
   790   C0443172:Changed [Quantitative Concept]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "25 mM glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "10% fetal bovine serum,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007452:Bovine [Mammal]
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0521457:Fetal [Functional Concept]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "1% penicillin-streptomycin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0038425:Streptomycin [Antibiotic,Carbohydrate]
Processing 00000000.tx.191: Cells were harvested 24 h after transfection, and firefly and Renilla luciferase activities were quantified with the Dual Luciferase Assay Kit (Promega Corp.). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "24 h after transfection,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "firefly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162328:Firefly [Eukaryote]

Phrase: "and"

Phrase: "Renilla luciferase activities"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   884   C1151115:luciferase activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "quantified with the Dual Luciferase Assay Kit (Promega Corp."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   742   C0005507:Assay [Laboratory Procedure]
   742   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   742   C0072149:Promega [Lipid]
   742   C0243073:assay [Qualitative Concept]
   742   C0683758:Corp. [Organization]
   742   C0812225:KIT [Medical Device]
   742   C1150635:KIT [Molecular Function]
   742   C1510438:Assay [Laboratory Procedure]
   742   C1554184:Dual [Intellectual Product]
   742   C1705212:Kit [Medical Device]
   742   C1705213:KIT [Medical Device]
   742   C3273202:Kit [Manufactured Object]
   708   C1709793:Quantify [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.192: Cell Fractionation To determine whether the mSPV is properly transported out of the nucleus and accessible for ribosome binding and translation in the cytoplasm in vivo, we obtained cytoplasmic fractions by performing cell fractionation as described previously (26, 27) using the mouse -cell line, Min6. 

Phrase: "Cell Fractionation To"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0007593:Cell Fractionation [Laboratory Procedure]
   827   C0016640:fractionation [Laboratory Procedure]
   827   C0524811:fractionation [Therapeutic or Preventive Procedure]
   827   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "determine"

Phrase: "whether"

Phrase: "the mSPV"

Phrase: "is"

Phrase: "properly"

Phrase: "transported out of the nucleus"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   781   C1526989:nucleus transport [Cell Function]
   760   C0007610:Nucleus [Cell Component]
   760   C0439787:Out [Spatial Concept]
   760   C0849355:Out [Qualitative Concept]
   726   C0005528:Transport, NOS [Cell Function]
   726   C1317949:Transport [Manufactured Object]
   726   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "accessible for ribosome binding"

Phrase: "and"

Phrase: "translation in the cytoplasm"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C3268327:cytoplasmic translation [Molecular Function]
   770   C0040712:Translation [Intellectual Product]
   770   C0597295:translation [Molecular Function]
   770   C1519614:Translation [Genetic Function]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "we"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "cytoplasmic fractions by performing cell fractionation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0805525:Cell fractions [Cell Component]
   753   C1264633:Fractions [Quantitative Concept]
   719 E C1554103:Fraction [Idea or Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(26,"

Phrase: "27"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the mouse -cell line,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1513528:Mouse Cell Line [Cell]
   901   C0007600:Cell Line [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "Min6."
Processing 00000000.tx.193: Cells were grown in high glucose DMEM (Invitrogen Life Technologies) with 10% fetal bovine serum, 1% penicillin-streptomycin, and 0.05 mM -mercaptoethanol. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown in high glucose DMEM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0860803:high glucose [Finding]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0205250:High [Qualitative Concept]
   760   C1299351:High [Qualitative Concept]
   760   C2700149:HIGH [Intellectual Product]

Phrase: "(Invitrogen Life Technologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0039421:technologies [Occupation or Discipline]

Phrase: ")"

Phrase: "with 10% fetal bovine serum,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007452:Bovine [Mammal]
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0521457:Fetal [Functional Concept]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "1% penicillin-streptomycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "and"

Phrase: "0.05 mM -mercaptoethanol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0025402:Mercaptoethanol [Organic Chemical]
Processing 00000000.tx.194: Cells were trypsinized, washed, and resuspended in 2 ml ice-cold lysis buffer containing 50 mM HEPES, 3 mM MgCl2, 0.3 M sucrose, and 10 l RNasin. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "trypsinized"

Phrase: ","

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: ","

Phrase: "and"

Phrase: "resuspended in 2 ml ice-cold lysis buffer"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0456963:Ice cold [Qualitative Concept]
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0009264:Cold [Natural Phenomenon or Process]
   744   C0009443:Cold [Disease or Syndrome]
   744   C0020746:Ice [Inorganic Chemical]
   744   C0024348:Lysis [Pathologic Function]
   744   C0234192:Cold [Physiologic Function]
   744   C0439526:/mL [Quantitative Concept]
   744   C1536403:lysis [Cell Function]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "50 mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "3 mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "0.3 M sucrose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "10 l RNasin."
Processing 00000000.tx.195: Cells were disrupted by passing them through a 20-gauge needle, and cell extract was centrifuged at 4 C for 1 h at approximately 100,000 x g. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "disrupted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:Disrupted [Qualitative Concept]

Phrase: "by passing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006539:BY [Geographic Area]
   827   C2828386:Pass [Finding]

Phrase: "them through a 20-gauge needle,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0450403:20 gauge [Quantitative Concept]
   783   C3640175:Needle Gauge [Quantitative Concept]
   753   C0027551:Needle [Medical Device]
   753   C0456564:Gauge [Spatial Concept]
   753   C1521879:GAGE [Immunologic Factor]
   753   C1704318:Needle [Medical Device]
   753   C1882041:Needle [Spatial Concept]

Phrase: "and"

Phrase: "cell extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2828366:Extract [Substance]

Phrase: "was"

Phrase: "centrifuged at 4 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0179834:centrifuge [Medical Device]

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at approximately 100,000 x g."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.196: The supernatant representing the cytoplasmic fraction was used for RNA extraction with TRIzol reagent according to the manufacturers instructions. 

Phrase: "The supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "the cytoplasmic fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "used for RNA extraction"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0185115:Extraction [Therapeutic or Preventive Procedure]
   770   C0684295:extraction [Laboratory Procedure]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "with TRIzol reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "according to the manufacturers instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.197: RNA Stability Assay To assess and compare the stabilities of the two mRNA species, the amounts of endogenous mNAT and mSPV mRNA were quantified after overall transcription was blocked by actinomycin D in Min6 -cells. 

Phrase: "RNA Stability"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0752249:RNA Stability [Qualitative Concept]
   861   C0205360:Stability [Qualitative Concept]
   861   C2347098:Stability [Qualitative Concept]
   789 E C1547311:Stable [Intellectual Product]

Phrase: "Assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "and"

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the stabilities of the two mRNA species,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   757   C1257757:mRNA Stability [Qualitative Concept]
   748   C0205360:stabilities [Qualitative Concept]
   714 E C2347098:Stability [Qualitative Concept]

Phrase: "the amounts of endogenous mNAT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "and"

Phrase: "mSPV mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "quantified after overall transcription"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0040649:Transcription [Genetic Function]
   770   C0282416:Overall [Intellectual Product]
   770   C1561607:Overall [Qualitative Concept]
   737   C1709793:Quantify [Quantitative Concept]

Phrase: "was"

Phrase: "blocked by actinomycin D"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0010934:Actinomycin D [Amino Acid, Peptide, or Protein,Antibiotic]
   770   C0001259:Actinomycin [Amino Acid, Peptide, or Protein,Antibiotic]
   770   C0028778:Blocked [Pathologic Function]
   770   C0332206:Blocked [Functional Concept]
   770   C2983591:BLOCKED [Research Activity]
   770   C3536807:Actinomycin [Pharmacologic Substance]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "in Min6 -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.198: Cells were grown to 7080% confluence as described above, the medium was changed, and 18 h later, cells were treated with actinomycin D (5 g/ml). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown to 7080% confluence"

Phrase: "as described above,"

Phrase: "the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "changed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:Changed [Functional Concept]
  1000   C0443172:Changed [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "18 h later,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with actinomycin D"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0010934:Actinomycin D [Amino Acid, Peptide, or Protein,Antibiotic]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0001259:Actinomycin [Amino Acid, Peptide, or Protein,Antibiotic]
   770   C1522326:Treated [Functional Concept]
   770   C3536807:Actinomycin [Pharmacologic Substance]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "(5 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1300565:g/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.199: RNA was extracted at different time points using TRIzol reagent, and samples were analyzed for mNAT or mSPV by quantitative real-time RT-PCR using primers 4 and 5 and probe 6 or primers 4 and 7 and probe 8 (Table 1), respectively. 

Phrase: "RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "extracted at different time points"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   773   C2348792:Time Point [Temporal Concept]
   762   C1442103:Time Difference [Temporal Concept]
   762   C1547049:*Time Difference [Quantitative Concept]
   760   C0040223:Time [Temporal Concept]
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C1705242:Different [Qualitative Concept]
   760   C3541383:Time [Temporal Concept]
   760   C3541890:EXTRACTED [Finding]
   726   C1552961:Point [Quantitative Concept]
   726   C2347617:point [Quantitative Concept]
   726 E C2828366:Extract [Substance]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "TRIzol reagent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "analyzed for mNAT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0936012:Analyzed [Research Activity]

Phrase: "or"

Phrase: "mSPV by quantitative real-time RT-PCR"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "probe 6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0182400:Probe [Medical Device]
   861   C1704681:Probe [Gene or Genome]
   861   C2347609:Probe [Chemical Viewed Functionally]
   861   C3536729:Probe [Manufactured Object]

Phrase: "or"

Phrase: "primers 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "7"

Phrase: "and"

Phrase: "probe 8"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0182400:Probe [Medical Device]
   861   C1704681:Probe [Gene or Genome]
   861   C2347609:Probe [Chemical Viewed Functionally]
   861   C3536729:Probe [Manufactured Object]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.200: The 18S ribosomal subunit was used as an internal standard, as described previously (10). 

Phrase: "The 18S ribosomal subunit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1956015:ribosomal subunit [Cell Component]
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "was"

Phrase: "used as an internal standard,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0205102:Internal [Spatial Concept]
   760   C1273517:used [Finding]
   760   C1442989:Standard [Qualitative Concept]
   760   C1553872:Internal [Intellectual Product]
   760   C1619620:Internal [Intellectual Product]
   760   C2828392:Standard [Intellectual Product]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.201: Secondary RNA Structure The predicted secondary RNA structures were analyzed using the Michael Zucker algorithm and the m-fold program as described previously (28, 29). 

Phrase: "Secondary RNA Structure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0162807:Secondary Structure [Spatial Concept]
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0678594:Structure [Spatial Concept]

Phrase: "The predicted secondary RNA structures"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0162807:Secondary Structure [Spatial Concept]
   812   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0678594:structures [Spatial Concept]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Michael Zucker algorithm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0002045:algorithm [Intellectual Product]
   827   C1553907:algorithm [Laboratory Procedure]

Phrase: "and"

Phrase: "the"

Phrase: "m-"

Phrase: "fold program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1709697:Program [Conceptual Entity]
   861   C2728259:Program [Pharmacologic Substance]
   861   C3484370:Program [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(28,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.202: Mouse Models and Islet Isolation To study the expression of the mSPV in diabetes and insulin resistance, the islets of three mouse models were studied. 

Phrase: "Mouse Models"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C2986594:Mouse Model [Experimental Model of Disease]
   861   C3161035:Models [Intellectual Product]

Phrase: "and"

Phrase: "Islet Isolation To"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0204727:Isolation [Therapeutic or Preventive Procedure]
   827   C0205409:Isolation [Functional Concept]
   827   C0220862:isolation [Laboratory Procedure]
   755 E C1548221:Isolated [Idea or Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the expression of the mSPV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "insulin resistance,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "the islets of three mouse models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   783   C1522528:Mouse Islets [Tissue]

Phrase: "were"

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.203: BTBR ob/ob mice are severely insulin resistant and overtly diabetic (13), and C57BL/6 ob/ob mice are insulin resistant, but not diabetic (13, 15). 

Phrase: "BTBR ob/ob mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   886   C1511028:BTBR Mouse [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "are"

Phrase: "severely insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "resistant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332325:Resistant [Functional Concept]
  1000   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "and"

Phrase: "overtly diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0241863:DIABETIC [Finding]

Phrase: "(13"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "C57BL/6 ob/ob mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   900   C1521751:C57BL/6 Mouse [Mammal]
   897   C0025921:Mice, C57BL [Mammal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "are"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "resistant,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332325:Resistant [Functional Concept]
  1000   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "but"

Phrase: "not diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0241863:DIABETIC [Finding]

Phrase: "(13,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.204: As a nonobese model of insulin resistance, A-ZIP/F1 lipoatrophic mice on the C57BL/6 background (C57BL/6 azip) were used (14, 16). 

Phrase: "As a nonobese model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "of insulin resistance,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "A-ZIP/F1 lipoatrophic mice on the C57BL/6 background"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   766   C1521751:C57BL/6 Mouse [Mammal]
   757   C0025921:Mice, C57BL [Mammal]
   741   C1522424:A Mouse [Mammal]
   739   C0025914:Mice [Mammal]
   739   C0025929:mice [Mammal]
   739   C0026809:Mice [Mammal]

Phrase: "(C57BL/6 azip"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1521751:C57BL/6 [Mammal]

Phrase: ")"

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "(14,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.205: All mouse studies were performed in accordance with the guidelines for the use and care of laboratory animals of University of Wisconsin or the NIH. 

Phrase: "All mouse studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "performed in accordance with the guidelines"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0162791:Guidelines [Intellectual Product]
   753   C0220845:guidelines [Intellectual Product]
   753   C0282423:guidelines [Intellectual Product]
   753   C0884358:Performed [Functional Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "for the use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "care of laboratory animals of University of Wisconsin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0178478:animals care [Occupation or Discipline]
   744   C1947933:Care [Activity]

Phrase: "or"

Phrase: "the NIH."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027468:NIH [Health Care Related Organization]
Processing 00000000.tx.206: Mouse islets from 6- to 14-wk-old diabetic and/or insulin-resistant mice as well as from the corresponding WT littermates were isolated and hand-picked as described previously (13, 30). 

Phrase: "Mouse islets from 6-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1522528:Mouse Islets [Tissue]

Phrase: "to 14-wk-old diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0241863:DIABETIC [Finding]

Phrase: "and/or"

Phrase: "insulin-resistant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "as well as from the corresponding WT littermates"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C1883559:Wild Type [Organism Attribute]
   742   C0205170:Well [Qualitative Concept]
   742   C0332307:Type [Qualitative Concept]
   742   C0445392:Wild [Intellectual Product]
   742   C1547052:*Type [Quantitative Concept]
   742   C3146287:Well [Manufactured Object]

Phrase: "were"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "hand-picked"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0018563:Hand [Body Part, Organ, or Organ Component]
   861   C1281583:Hand [Body Part, Organ, or Organ Component]
   861   C1552914:hand [Quantitative Concept]
   861   C1707391:Picked [Activity]
   827 E C1826583:PICK [Gene or Genome]
   805 E C0024763:Manual [Intellectual Product,Manufactured Object]
   805 E C0175674:Manual [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(13,"

Phrase: "30"

Phrase: ")."
Processing 00000000.tx.207: All ob/ob mice and their controls were males, all azip mice and their littermates were females; 

Phrase: "All ob/ob mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "their controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "males,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0024554:Males [Finding]
  1000   C0086582:Males [Population Group]
   966 E C1706180:Male [Qualitative Concept]
   966 E C1706428:Male [Qualitative Concept]
   966 E C1706429:Male [Organism Attribute]

Phrase: "all azip mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "their littermates"

Phrase: "were"

Phrase: "females"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0015780:Females [Finding]
  1000   C0086287:Females [Population Group]
   966 E C0043210:female [Population Group]
   966 E C1705497:Female [Qualitative Concept]
   966 E C1705498:Female [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.208: islets from this latter group were a gift from Drs. 

Phrase: "islets from this latter group"

Phrase: "were"

Phrase: "a gift from Drs."
Processing 00000000.tx.209: O. 

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.210: Gavrilova and C. 

Phrase: "Gavrilova"

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.211: Vinson, NIH. 

Phrase: "Vinson,"

Phrase: "NIH."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027468:NIH [Health Care Related Organization]
Processing 00000000.tx.212: Islets from three to six mice were pooled per sample. 

Phrase: "Islets from three"

Phrase: "to six mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "pooled per sample."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   858   C1709595:Pooled Sample [Conceptual Entity]
           Pooled
   841 E C1509144:Sample pool [Clinical Attribute]
       E   pool
   790   C0370003:Sample [Substance]
   790   C2347026:Sample [Conceptual Entity]
   790   C2349200:Pooled [Functional Concept]
   756 E C0337051:Pool [Geographic Area]
Processing 00000000.tx.213: Total RNA was extracted from mouse islets with TRIzol reagent according to the manufacturers instructions. 

Phrase: "Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "extracted from mouse islets"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C1522528:Mouse Islets [Tissue]
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C3541890:EXTRACTED [Finding]
   737 E C2828366:Extract [Substance]

Phrase: "with TRIzol reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "according to the manufacturers instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.214: Quantitative Real-Time RT-PCR RT was performed with the First Strand cDNA synthesis kit (Roche), and quantitative real-time PCR was performed on a PRISM 7000 TaqMan apparatus (Applied Biosystems, Foster City, CA). 

Phrase: "Quantitative Real-Time RT-PCR RT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   700   C1709846:Real-Time PCR [Molecular Biology Research Technique]

Phrase: "was"

Phrase: "performed with the First Strand cDNA synthesis kit (Roche"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   742   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0205435:First [Quantitative Concept]
   742   C0220781:synthesis [Biologic Function]
   742   C0331965:Roche [Health Care Related Organization]
   742   C0812225:KIT [Medical Device]
   742   C0884358:Performed [Functional Concept]
   742   C1150635:KIT [Molecular Function]
   742   C1279901:First [Qualitative Concept]
   742   C1704972:Strand [Spatial Concept]
   742   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C1705212:Kit [Medical Device]
   742   C1705213:KIT [Medical Device]
   742   C1883254:Synthesis [Activity]
   742   C3273202:Kit [Manufactured Object]
   708 E C2947996:Perform [Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "quantitative real-time PCR"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   923   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   861   C1550177:Real Time [Idea or Concept]
   812   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0040223:Time [Temporal Concept]
   812   C0237400:Real [Qualitative Concept]
   812   C0392762:Quantitative [Quantitative Concept]
   812   C0677874:pCR [Finding]
   812   C3272377:REAL [Intellectual Product]
   812   C3541383:Time [Temporal Concept]
   756 E C0442043:Temporal [Spatial Concept]
   756 E C2362314:Temporal [Temporal Concept]
   729 E C1632851:Times [Quantitative Concept]

Phrase: "was"

Phrase: "performed on a PRISM 7000 TaqMan apparatus"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0243111:apparatus [Manufactured Object]
   748   C0814195:PRISM [Intellectual Product]
   748   C0884358:Performed [Functional Concept]
   748   C1947951:Apparatus [Anatomical Structure]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Applied Biosystems,"

Phrase: "Foster City,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0008848:City [Geographic Area]
   861   C0242298:foster [Daily or Recreational Activity]
   861   C0344349:foster [Family Group]
   861   C3262831:City [Clinical Attribute]

Phrase: "CA)."
Processing 00000000.tx.215: Primers 4 and 5 and probe 6 (Table 1) specifically detected mNAT, whereas primers 4 and 7 and probe 8 (Table 1) selectively measured mSPV. 

Phrase: "Primers 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "probe 6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0182400:Probe [Medical Device]
   861   C1704681:Probe [Gene or Genome]
   861   C2347609:Probe [Chemical Viewed Functionally]
   861   C3536729:Probe [Manufactured Object]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "specifically detected mNAT,"

Phrase: "whereas"

Phrase: "primers 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "7"

Phrase: "and"

Phrase: "probe 8"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0182400:Probe [Medical Device]
   861   C1704681:Probe [Gene or Genome]
   861   C2347609:Probe [Chemical Viewed Functionally]
   861   C3536729:Probe [Manufactured Object]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "selectively measured mSPV."
Processing 00000000.tx.216: For analysis of the mouse insulin 1 gene, primers 912 (Table 1) were used. 

Phrase: "For analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "of the mouse insulin 1 gene,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C1337112:Insulin Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]

Phrase: "primers 912"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.217: All measurements were performed in triplicate. 

Phrase: "All measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:measurements [Functional Concept]

Phrase: "were"

Phrase: "performed in triplicate."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205174:Triplicate [Quantitative Concept]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.218: Statistical Analysis Data are presented as the mean  SEM. 

Phrase: "Statistical Analysis Data"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C2828391:statistical data [Quantitative Concept]
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   734   C0871424:statistical analysis [Research Activity]

Phrase: "are"

Phrase: "presented as the mean  SEM."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0444504:Mean [Quantitative Concept]
   760   C0449450:Presented [Idea or Concept]
   760   C2347634:Mean [Quantitative Concept]
   760   C2348143:Mean [Quantitative Concept]
   726 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.219: Unless stated otherwise, P values were calculated using two-tailed t tests.  

Phrase: "Unless"

Phrase: "stated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1301808:stated [Geographic Area]
  1000   C1442792:Stated [Functional Concept]
   966 E C3148680:State [Geographic Area]

Phrase: "otherwise,"

Phrase: "P values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709380:P-Value [Quantitative Concept]
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "two-tailed t tests."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0022885:Tests [Laboratory Procedure]
   812   C0392366:Tests [Intellectual Product]
   779 E C0039593:Test [Functional Concept]
Processing 00000000.tx.220: FOOTNOTES  This work was supported by Grant 7-03-JF-37 from the American Diabetes Association (to A.S.) and National Institute of Diabetes and Digestive and Kidney Diseases Grant 58037-01 (to A.D.A.). 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by Grant 7-03-JF-37"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0018173:Grant [Quantitative Concept]
   748   C1521721:Supported [Conceptual Entity]
   748   C1548284:Grant [Idea or Concept]
   714 E C0183683:Support [Medical Device]

Phrase: "from the American Diabetes Association"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1705019:American Diabetes Association [Professional Society]
   827   C0004083:Association [Mental Process]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0439849:Association [Qualitative Concept]
   827   C0596070:American [Population Group]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "("

Phrase: "to A.S."

Phrase: ")"

Phrase: "and"

Phrase: "National Institute of Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "and"

Phrase: "Digestive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012238:Digestive [Organism Function]
  1000   C0012240:Digestive [Body System]

Phrase: "and"

Phrase: "Kidney Diseases Grant 58037-01"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   840   C0022658:Kidney Diseases [Disease or Syndrome]
   804   C0012634:Diseases [Disease or Syndrome]
   804   C0018173:Grant [Quantitative Concept]
   804   C0022646:Kidney [Body Part, Organ, or Organ Component]
   804   C0227665:kidney [Body Part, Organ, or Organ Component]
   804   C1278978:Kidney [Body Part, Organ, or Organ Component]
   804   C1514845:KIDNEY [Tissue]
   804   C1548284:Grant [Idea or Concept]
   733 E C1836721:MALS [Finding]
   733 E C3538764:MALS [Gene or Genome]
   733 E C3540595:MAL [Gene or Genome]
   711 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "("

Phrase: "to A.D.A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: ")."
Processing 00000000.tx.221: First Published Online November 18, 2004 Abbreviations: mNAT, Mouse native insulin; 

Phrase: "First"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: "Online November 18,"

Phrase: "2004 Abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0000723:Abbreviations [Intellectual Product]

Phrase: ":"

Phrase: "mNAT,"

Phrase: "Mouse native insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.222: mSPV, mouse insulin splice-variant; 

Phrase: "mSPV,"

Phrase: "mouse insulin splice-variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205419:Variant [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.223: SPV, splice-variant; 

Phrase: "SPV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "splice-variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.224: 5'UTR, 5'-untranslated region; 

Phrase: "5'UTR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0600493:5' UTR [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0600680:UTR [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1420099:UTR [Gene or Genome]
   861   C1540171:UTR [Gene or Genome]

Phrase: "5'-untranslated region"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0600493:5' Untranslated Region [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   913   C1883644:5' Region [Nucleotide Sequence]
   901   C0600680:Untranslated Region [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.225: WT, wild-type. 

Phrase: "WT, wild-type."
Processing 00000000.tx.226: Received for publication March 19, 2004. 

Phrase: "Received for publication March 19,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "2004."
Processing 00000000.tx.227: Accepted for publication November 9, 2004.  

Phrase: "Accepted for publication November 9,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1272684:Accepted [Qualitative Concept]
   760   C1548435:Accepted [Idea or Concept]
   760   C1704324:Publication [Intellectual Product]
   726 E C1548601:Accept [Idea or Concept]

Phrase: "2004."
Processing 00000000.tx.228: REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Itoh N, Okamoto H 1980 Translational control of proinsulin synthesis by glucose. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Itoh N,"

Phrase: "Okamoto H 1980 Translational control of proinsulin synthesis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0243148:control [Qualitative Concept]
   744   C1519614:Translational [Genetic Function]
   744   C1550141:Control [Substance]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C3274648:Control [Qualitative Concept]

Phrase: "by glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.229: Nature 283:100102[Medline] Welsh M, Scherberg N, Gilmore R, Steiner DF 1986 Translational control of insulin biosynthesis. 

Phrase: "Nature 283"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "100102"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Welsh M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Scherberg N,"

Phrase: "Gilmore R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Steiner DF 1986 Translational control of insulin biosynthesis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0243148:control [Qualitative Concept]
   744   C1519614:Translational [Genetic Function]
   744   C1550141:Control [Substance]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.230: Evidence for regulation of elongation, initiation and signal-recognition-particle-mediated translational arrest by glucose. 

Phrase: "Evidence for regulation of elongation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "initiation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0589507:Initiation [Mental Process]
  1000   C1158830:Initiation [Genetic Function]
  1000   C1704686:Initiation [Functional Concept]

Phrase: "and"

Phrase: "signal-recognition-particle-mediated translational arrest by glucose."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0237477:Arrest [Temporal Concept]
   744   C0392351:arrest [Governmental or Regulatory Activity]
Processing 00000000.tx.231: Biochem J 235:459467[Medline] Skelly RH, Schuppin GT, Ishihara H, Oka Y, Rhodes CJ 1996 Glucose-regulated translational control of proinsulin biosynthesis with that of the proinsulin endopeptidases PC2 and PC3 in the insulin-producing MIN6 cell line. 

Phrase: "Biochem J 235"

Phrase: ":"

Phrase: "459467"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Skelly RH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: "Schuppin GT,"

Phrase: "Ishihara H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Oka Y,"

Phrase: "Rhodes CJ 1996 Glucose-regulated translational control of proinsulin biosynthesis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   757   C0726398:GLUCOSE CONTROL [Indicator, Reagent, or Diagnostic Aid]
   739   C0243148:control [Qualitative Concept]
   739   C1519614:Translational [Genetic Function]
   739   C1550141:Control [Substance]
   739   C1882979:Control [Conceptual Entity]
   739   C2587213:Control [Functional Concept]
   739   C3274648:Control [Qualitative Concept]

Phrase: "with that"

Phrase: "of the proinsulin endopeptidases PC2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   884   C0083957:Endopeptidase PC2 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "PC3 in the insulin-producing MIN6 cell line."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2677316:PC-3 [Gene or Genome]
Processing 00000000.tx.232: Diabetes 45:3743[Abstract] Rhodes CJ 1996 Processing of the insulin molecule. 

Phrase: "Diabetes 45"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "3743"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Rhodes CJ 1996 Processing of the insulin molecule."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1158354:insulin processing [Molecular Function]
   744   C1709694:Processing [Activity]
Processing 00000000.tx.233: In: LeRoith D, Taylor SI, Olefsky JM, eds. 

Phrase: "In"

Phrase: ":"

Phrase: "LeRoith D,"

Phrase: "Taylor SI,"

Phrase: "Olefsky JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "eds."
Processing 00000000.tx.234: Diabetes mellitus. 

Phrase: "Diabetes mellitus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]
Processing 00000000.tx.235: Philadelphia: Lippincott-Raven; 

Phrase: "Philadelphia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031525:Philadelphia [Geographic Area]

Phrase: ":"

Phrase: "Lippincott-Raven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1449597:Raven [Bird]

Phrase: ";"
Processing 00000000.tx.236: 2741 Goodge KA, Hutton JC 2000 Translational regulation of proinsulin biosynthesis and proinsulin conversion in the pancreatic -cell. 

Phrase: "2741 Goodge KA,"

Phrase: "Hutton JC 2000 Translational regulation of proinsulin biosynthesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C1157723:regulation of biosynthesis [Molecular Function]
   770   C3537096:Translational Regulation [Genetic Function]
   769   C1157519:regulation of translation [Cell Function]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "proinsulin conversion in the pancreatic -cell."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439836:Conversion [Functional Concept]
Processing 00000000.tx.237: Semin Cell Dev Biol 11:235242[CrossRef][Medline] Hentze MW, Rouault TA, Caughman SW, Dancis A, Harford JB, Klausner RD 1987 A cis-acting element is necessary and sufficient for translational regulation of human ferritin expression in response to iron. 

Phrase: "Semin Cell Dev Biol 11"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0007634:Cell [Cell]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "235242"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hentze MW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024548:MW [Geographic Area]
   861   C0026385:mw [Quantitative Concept]
   861   C0556966:mW [Quantitative Concept]

Phrase: "Rouault TA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: "Caughman SW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1420193:SW [Gene or Genome]
   861   C1832169:SW [Body System]
   861   C3538902:SW [Gene or Genome]

Phrase: "Dancis A,"

Phrase: "Harford JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: "Klausner RD 1987"

Phrase: "A cis-acting element"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599780:cis acting element [Nucleotide Sequence]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C1705248:Element [Conceptual Entity]

Phrase: "is"

Phrase: "necessary"

Phrase: "and"

Phrase: "sufficient for translational regulation of human ferritin expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205410:Sufficient [Qualitative Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to iron."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]
Processing 00000000.tx.238: Proc Natl Acad Sci USA 84:67306734[Abstract] Wicksteed B, Herbert TP, Alarcon C, Lingohr MK, Moss LG, Rhodes CJ 2001 Cooperativity between the preproinsulin mRNA untranslated regions is necessary for glucose-stimulated translation. 

Phrase: "Proc Natl Acad Sci USA 84"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "67306734"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Wicksteed B,"

Phrase: "Herbert TP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541334:TP [Gene or Genome]

Phrase: "Alarcon C,"

Phrase: "Lingohr MK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539059:MK [Idea or Concept]

Phrase: "Moss LG,"

Phrase: "Rhodes CJ 2001 Cooperativity between the preproinsulin mRNA untranslated regions"

Phrase: "is"

Phrase: "necessary for glucose-stimulated translation."
Processing 00000000.tx.239: J Biol Chem 276:2255322558[Abstract/Free FullText] van der Velden AW, Thomas AA 1999 The role of the 5' untranslated region of an mRNA in translation regulation during development. 

Phrase: "J Biol Chem 276"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2255322558"

Phrase: "[Abstract/Free FullText"

Phrase: "] van der Velden AW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0282379:AW [Geographic Area]
   812   C0332281:AW [Qualitative Concept]

Phrase: "Thomas AA 1999"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1235746:Aa [Plant]
   827   C1882141:aa [Qualitative Concept]

Phrase: "The role of the 5' untranslated region of an mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]

Phrase: "in translation regulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C3537096:Translational Regulation [Genetic Function]
   861   C0851285:Regulation [Governmental or Regulatory Activity]
   861   C1327622:Regulation [Biologic Function]

Phrase: "during development."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]
Processing 00000000.tx.240: Int J Biochem Cell Biol 31:87106[CrossRef][Medline] Thomson AM, Rogers JT, Leedman PJ 1999 Iron-regulatory proteins, iron-responsive elements and ferritin mRNA translation. 

Phrase: "Int J Biochem Cell Biol 31"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0007634:Cell [Cell]
   799   C0063789:INT [Organic Chemical]
   799   C0450355:31 [Intellectual Product]
   799   C1269647:Cell [Cell]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]
   799   C3272375:INT [Intellectual Product]

Phrase: ":"

Phrase: "87106"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Thomson"

Phrase: "AM"

Phrase: ","

Phrase: "Rogers JT,"

Phrase: "Leedman PJ 1999 Iron-regulatory proteins,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0378503:Iron-Regulatory Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0815047:regulatory proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0220905:regulatory [Regulation or Law]
   799   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   799   C0376520:Iron [Inorganic Chemical]
   799   C1166521:iron [Pharmacologic Substance]
   799   C1704735:Regulatory [Conceptual Entity]

Phrase: "iron-responsive elements"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0013879:Elements [Element, Ion, or Isotope]
   827   C0205342:Responsive [Functional Concept]
   827   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0376520:Iron [Inorganic Chemical]
   827   C1166521:iron [Pharmacologic Substance]
   793 E C1705248:Element [Conceptual Entity]
   755 E C2371924:Responsivity [Mental Process]

Phrase: "and"

Phrase: "ferritin mRNA translation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0597295:mRNA Translation [Molecular Function]
           translation
   827   C0040712:Translation [Intellectual Product]
   827   C1519614:Translation [Genetic Function]
Processing 00000000.tx.241: Int J Biochem Cell Biol 31:11391152[CrossRef][Medline] Shalev A, Blair PJ, Hoffmann SC, Hirshberg B, Peculis BA, Harlan DM 2002 A proinsulin gene splice variant with increased translation efficiency is expressed in human pancreatic islets. 

Phrase: "Int J Biochem Cell Biol 31"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0007634:Cell [Cell]
   799   C0063789:INT [Organic Chemical]
   799   C0450355:31 [Intellectual Product]
   799   C1269647:Cell [Cell]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]
   799   C3272375:INT [Intellectual Product]

Phrase: ":"

Phrase: "11391152"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shalev A,"

Phrase: "Blair PJ,"

Phrase: "Hoffmann SC,"

Phrase: "Hirshberg B,"

Phrase: "Peculis BA,"

Phrase: "Harlan DM 2002"

Phrase: "A proinsulin gene splice variant with increased translation efficiency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205419:Variant [Qualitative Concept]

Phrase: "is"

Phrase: "expressed in human pancreatic islets."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   760   C0086418:Human [Human]
Processing 00000000.tx.242: Endocrinology 143:25412547[Abstract/Free FullText] Minn AH, Kayton M, Lorang D, Hoffmann SC, Harlan DM, Libutti SK, Shalev A 2004 Insulinomas and expression of an insulin splice variant. 

Phrase: "Endocrinology 143"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "25412547"

Phrase: "[Abstract/Free FullText"

Phrase: "] Minn AH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1836672:AH [Disease or Syndrome]

Phrase: "Kayton M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lorang D,"

Phrase: "Hoffmann SC,"

Phrase: "Harlan DM,"

Phrase: "Libutti SK,"

Phrase: "Shalev"

Phrase: "A 2004 Insulinomas"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021670:Insulinomas [Neoplastic Process]

Phrase: "and"

Phrase: "expression of an insulin splice variant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.243: Lancet 363:363367[CrossRef][Medline] Gray NK, Hentze MW 1994 Regulation of protein synthesis by mRNA structure. 

Phrase: "Lancet 363"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: ":"

Phrase: "363367"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gray NK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022688:NK [Cell]

Phrase: "Hentze MW 1994 Regulation of protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C1157519:regulation of protein synthesis [Cell Function]
   804   C1157723:regulation of synthesis [Molecular Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "by mRNA structure."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]
Processing 00000000.tx.244: Mol Biol Rep 19:195200[Medline] Lan H, Rabaglia ME, Stoehr JP, Nadler ST, Schueler KL, Zou F, Yandell BS, Attie AD 2003 Gene expression profiles of nondiabetic and diabetic obese mice suggest a role of hepatic lipogenic capacity in diabetes susceptibility. 

Phrase: "Mol Biol Rep 19"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1744664:REP [Molecular Function]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "195200"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lan H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Rabaglia"

Phrase: "ME,"

Phrase: "Stoehr JP,"

Phrase: "Nadler ST,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "Schueler KL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1366480:KL [Gene or Genome]
   861   C1416656:KL [Gene or Genome]

Phrase: "Zou F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Yandell BS,"

Phrase: "Attie AD 2003 Gene expression profiles of nondiabetic"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   800   C1956267:Gene Expression Profiles [Quantitative Concept]
   783 E C1449575:gene expression profile [Laboratory Procedure]
   711   C1979963:Profile [Laboratory Procedure]
   711   C2003903:Profile [Functional Concept]

Phrase: "and"

Phrase: "diabetic obese mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0025933:Mice, Obese [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a role of hepatic lipogenic capacity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in diabetes susceptibility."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0012655:Susceptibility [Clinical Attribute]
   861   C0220898:Susceptibility [Organism Attribute]
   861   C1264642:Susceptibility [Functional Concept]
   861   C1547045:*Susceptibility [Quantitative Concept]
   789 E C0231204:Susceptible [Functional Concept]
   789 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]
Processing 00000000.tx.245: Diabetes 52:688700[Abstract/Free FullText] Moitra J, Mason MM, Olive M, Krylov D, Gavrilova O, Marcus-Samuels B, Feigenbaum L, Lee E, Aoyama T, Eckhaus M, Reitman ML, Vinson C 1998 Life without white fat: a transgenic mouse. 

Phrase: "Diabetes 52"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "688700"

Phrase: "[Abstract/Free FullText"

Phrase: "] Moitra J,"

Phrase: "Mason MM,"

Phrase: "Olive M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Krylov D,"

Phrase: "Gavrilova O,"

Phrase: "Marcus-Samuels B,"

Phrase: "Feigenbaum L,"

Phrase: "Lee E,"

Phrase: "Aoyama T,"

Phrase: "Eckhaus M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Reitman ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Vinson C 1998 Life without white fat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0376558:Life [Idea or Concept]

Phrase: ":"

Phrase: "a transgenic mouse."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mouse, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]
Processing 00000000.tx.246: Genes Dev 12:316831681[Abstract/Free FullText] Ranheim T, Dumke C, Schueler KL, Cartee GD, Attie AD 1997 Interaction between BTBR and C57BL/6J genomes produces an insulin resistance syndrome in (BTBR x C57BL/6J) F1 mice. 

Phrase: "Genes Dev 12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: ":"

Phrase: "316831681"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ranheim T,"

Phrase: "Dumke C,"

Phrase: "Schueler KL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1366480:KL [Gene or Genome]
   861   C1416656:KL [Gene or Genome]

Phrase: "Cartee GD,"

Phrase: "Attie AD 1997 Interaction between BTBR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "C57BL/6J genomes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0017428:Genomes [Gene or Genome]
   793 E C2338314:Genome [Conceptual Entity]

Phrase: "produces"

Phrase: "an insulin resistance syndrome in (BTBR x C57BL/6J"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0524620:Insulin Resistance Syndrome X [Disease or Syndrome]

Phrase: ")"

Phrase: "F1 mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.247: Arterioscler Thromb Vasc Biol 17:32863293[Abstract/Free FullText] Reitman ML, Mason MM, Moitra J, Gavrilova O, Marcus-Samuels B, Eckhaus M, Vinson C 1999 Transgenic mice lacking white fat: models for understanding human lipoatrophic diabetes. 

Phrase: "Arterioscler Thromb Vasc Biol 17"

Phrase: ":"

Phrase: "32863293"

Phrase: "[Abstract/Free FullText"

Phrase: "] Reitman ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Mason MM,"

Phrase: "Moitra J,"

Phrase: "Gavrilova O,"

Phrase: "Marcus-Samuels B,"

Phrase: "Eckhaus M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Vinson C 1999 Transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0025936:Mice, Transgenic [Mammal]
   804   C0003069:Transgenic [Animal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "white fat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704223:White Fat [Tissue]
   861   C0424612:FAT [Organism Attribute]

Phrase: ":"

Phrase: "models for understanding human lipoatrophic diabetes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Models [Intellectual Product]
Processing 00000000.tx.248: Ann NY Acad Sci 892:289296[Abstract/Free FullText] Lou H, Gagel RF 2001 Alternative ribonucleic acid processing in endocrine systems. 

Phrase: "Ann NY Acad Sci 892"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0027976:NY [Geographic Area]
   804   C0268596:ACAD [Disease or Syndrome]
   804   C1879958:NY [Intellectual Product]
   804   C2700624:ACAD [Cell Function]
   804   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "289296"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lou H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Gagel RF 2001 Alternative ribonucleic acid processing in endocrine systems."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1709694:Processing [Activity]
Processing 00000000.tx.249: Endocr Rev 22:205225[Abstract/Free FullText] Weir GC, Laybutt DR, Kaneto H, Bonner-Weir S, Sharma A 2001 Beta-cell adaptation and decompensation during the progression of diabetes. 

Phrase: "Endocr Rev 22"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "205225"

Phrase: "[Abstract/Free FullText"

Phrase: "] Weir GC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3537453:GC [Gene or Genome]

Phrase: "Laybutt DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "Kaneto H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Bonner-Weir S,"

Phrase: "Sharma"

Phrase: "A 2001 Beta-cell adaptation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0000934:adaptation [Organism Function]
   812   C0392673:Adaptation [Biologic Function]

Phrase: "and"

Phrase: "decompensation during the progression of diabetes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0231187:Decompensation [Finding]
Processing 00000000.tx.250: Diabetes 50(Suppl 1):S154S159 Bonner-Weir S 2001 -Cell turnover: its assessment and implications. 

Phrase: "Diabetes 50"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(Suppl 1"

Phrase: ")"

Phrase: ":"

Phrase: "S154S159 Bonner-Weir S 2001 -Cell turnover"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0031227:turnover [Quantitative Concept]
   795   C0243127:turnover [Functional Concept]
   795   C0443331:Turnover [Health Care Activity]

Phrase: ":"

Phrase: "its assessment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1261322:Assessment [Health Care Activity]
  1000   C1516048:Assessment [Activity]

Phrase: "and"

Phrase: "implications."
Processing 00000000.tx.251: Diabetes 50(Suppl 1):S20S24 Butler AE, Janson J, Soeller WC, Butler PC 2003 Increased -cell apoptosis prevents adaptive increase in -cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. 

Phrase: "Diabetes 50"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(Suppl 1"

Phrase: ")"

Phrase: ":"

Phrase: "S20S24 Butler AE,"

Phrase: "Janson J,"

Phrase: "Soeller WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Butler PC 2003"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0402644:Butler [Professional or Occupational Group]
   827   C3540812:PC [Gene or Genome]

Phrase: "Increased -"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "cell apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "adaptive increase in -cell mass in mouse model of type 2 diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0577559:Mass [Finding]
   736   C1306372:*Mass [Quantitative Concept]
   736   C3152252:Mass [Quantitative Concept]

Phrase: ":"

Phrase: "evidence for role of islet amyloid formation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "rather than"

Phrase: "direct action of amyloid."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439851:Direct [Qualitative Concept]
   770   C0441472:Action [Functional Concept]
   770   C1947931:Direct [Qualitative Concept]
   770   C3266814:Action [Activity]
Processing 00000000.tx.252: Diabetes 52:23042314[Abstract/Free FullText] Kahn SE 2003 The relative contributions of insulin resistance and -cell dysfunction to the pathophysiology of type 2 diabetes. 

Phrase: "Diabetes 52"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "23042314"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kahn SE 2003"

Phrase: "The relative contributions of insulin resistance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1880177:Contribution [Activity]

Phrase: "and -"

Phrase: "cell dysfunction to the pathophysiology of type 2 diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0031847:dysfunction [Functional Concept]
   742   C0277785:Dysfunction, NOS [Qualitative Concept]
Processing 00000000.tx.253: Diabetologia 46:319[Medline] Kahn SE 2001 Clinical review 135: the importance of -cell failure in the development and progression of type 2 diabetes. 

Phrase: "Diabetologia 46"

Phrase: ":"

Phrase: "319"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kahn SE 2001 Clinical review 135"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0205210:Clinical [Qualitative Concept]
   799   C0282443:Review [Intellectual Product]
   799   C1552617:Review [Idea or Concept]

Phrase: ":"

Phrase: "the importance of -cell failure in the development"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0231174:Failure [Functional Concept]
   744   C0680095:failure [Individual Behavior]

Phrase: "and"

Phrase: "progression of type 2 diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0242656:progression [Pathologic Function]
   760   C0449258:Progression [Functional Concept]
Processing 00000000.tx.254: J Clin Endocrinol Metab 86:40474058[Free FullText] Polonsky KS, Sturis J, Bell GI 1996 Seminars in medicine of the Beth Israel Hospital, Boston. 

Phrase: "J Clin Endocrinol Metab 86"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "40474058"

Phrase: "[Free FullText"

Phrase: "] Polonsky KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Sturis J,"

Phrase: "Bell GI 1996 Seminars in medicine of the Beth Israel Hospital,"

Phrase: "Boston."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]
Processing 00000000.tx.255: Non-insulin-dependent diabetes mellitus: a genetically programmed failure of the  cell to compensate for insulin resistance. 

Phrase: "Non-insulin-dependent diabetes mellitus"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
  1000   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
  1000   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   937   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   840   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0851827:Dependent [Qualitative Concept]
   804   C1518422:Non [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1701901:Dependent [Qualitative Concept]
   804   C3244310:dependent [Functional Concept]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ":"

Phrase: "a genetically programmed failure of the  cell to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0231174:Failure [Functional Concept]
   744   C0680095:failure [Individual Behavior]

Phrase: "compensate for insulin resistance."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0205432:compensate [Qualitative Concept]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.256: N Engl J Med 334:777783[Free FullText] Lingohr MK, Buettner R, Rhodes CJ 2002 Pancreatic -cell growth and survivala role in obesity-linked type 2 diabetes? 

Phrase: "N Engl J Med 334"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441922:N+ [Intellectual Product]
   804   C1414400:ENGL [Gene or Genome]
   804   C1553036:[n] [Quantitative Concept]

Phrase: ":"

Phrase: "777783"

Phrase: "[Free FullText"

Phrase: "] Lingohr MK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539059:MK [Idea or Concept]

Phrase: "Buettner R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Rhodes CJ 2002 Pancreatic -cell growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0007595:Cell Growth [Cell Function]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0220844:growth [Physiologic Function]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "survivala role in obesity-linked type 2 diabetes?"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.257: Trends Mol Med 8:375384[CrossRef][Medline] Gerich JE 2003 Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Mol Med 8"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0027960:Mole [Neoplastic Process]
   827   C0324740:Mole [Mammal]
   827   C0439189:Mole [Quantitative Concept]
   827   C1456781:mole [Neoplastic Process]
   827   C1824986:mol [Gene or Genome]
   743 E C0026367:Molar [Body Part, Organ, or Organ Component]
   727 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "375384"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gerich JE 2003 Contributions of insulin-resistance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1880177:Contribution [Activity]

Phrase: "and"

Phrase: "insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   738   C0243067:defects [Functional Concept]
   704 E C1457869:Defect [Functional Concept]
   704 E C1861101:DEFECT [Disease or Syndrome]
Processing 00000000.tx.258: Mayo Clin Proc 78:447456[Medline] Widnell CC, Tata JR 1964 A procedure for the isolation of enzymically active rat-liver nuclei. 

Phrase: "Mayo Clin Proc 78"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0454788:Mayo [Geographic Area]
   812   C1077578:mayo [Plant]
   812   C1315013:CLIN [Intellectual Product]
   812   C1418943:PROC [Gene or Genome]

Phrase: ":"

Phrase: "447456"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Widnell CC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538933:CC [Cell Component]

Phrase: "Tata JR 1964"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: "A procedure for the isolation of enzymically active rat-liver nuclei."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   754   C0204727:Isolation procedure [Therapeutic or Preventive Procedure]
   754   C0872387:liver procedure [Health Care Activity]
   738   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   738   C1948041:Procedure [Therapeutic or Preventive Procedure]
   738   C2700391:Procedure [Activity]
   738   C3274430:PROCEDURE [Health Care Activity]
   738   C3538935:Procedure [Idea or Concept]
   738   C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.259: Biochem J 92:313317[Medline] Albarracin CT, Palfrey HC, Duan WR, Rao MC, Gibori G 1994 Prolactin regulation of the calmodulin-dependent protein kinase III elongation factor-2 system in the rat corpus luteum. 

Phrase: "Biochem J 92"

Phrase: ":"

Phrase: "313317"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Albarracin CT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]

Phrase: "Palfrey HC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020268:HC [Hormone,Pharmacologic Substance,Steroid]
   861   C1413512:Hc [Gene or Genome]

Phrase: "Duan WR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1420193:WR [Gene or Genome]
   861   C1425679:WR [Gene or Genome]
   861   C1862190:WR [Immunologic Factor]
   861   C3538902:WR [Gene or Genome]

Phrase: "Rao MC,"

Phrase: "Gibori G 1994 Prolactin regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0851285:Regulation [Governmental or Regulatory Activity]
   804   C1327622:Regulation [Biologic Function]

Phrase: "of the calmodulin-dependent protein kinase III elongation factor-2 system"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   791   C0449913:System [Functional Concept]
   791   C1553451:System [Manufactured Object]
   791   C1704459:System [Medical Device]
   720 E C0205373:Systemic [Functional Concept]
   712   C1413089:CALMODULIN 2 [Gene or Genome]
   707   C0054521:calmodulin-dependent protein kinase III [Amino Acid, Peptide, or Protein,Enzyme]
   707   C1539329:CALMODULIN-DEPENDENT PROTEIN KINASE III [Gene or Genome]

Phrase: "in the rat corpus luteum."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0010092:Corpus Luteum [Body Part, Organ, or Organ Component]
   827   C0227813:Corpus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.260: J Biol Chem 269:77727776[Abstract/Free FullText] Zuker M, Jaeger JA, Turner DH 1991 A comparison of optimal and suboptimal RNA secondary structures predicted by free energy minimization with structures determined by phylogenetic comparison. 

Phrase: "J Biol Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "77727776"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zuker M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Jaeger JA,"

Phrase: "Turner DH 1991"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1832586:DH [Disease or Syndrome]

Phrase: "A comparison of optimal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "suboptimal RNA secondary structures"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0162807:Secondary Structure [Spatial Concept]
   812   C0027627:secondary [Neoplastic Process]
   812   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0175668:Secondary [Temporal Concept]
   812   C0205436:Secondary [Quantitative Concept]
   812   C0678594:structures [Spatial Concept]

Phrase: "predicted by free energy minimization"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0678591:Free Energy [Natural Phenomenon or Process]
   760   C0332296:free [Functional Concept]
   760   C0424589:Energy [Finding]
   760   C0542479:Energy [Natural Phenomenon or Process]
   760   C0681842:Predicted [Idea or Concept]
   760   C1442080:Energy [Quantitative Concept]
   760   C1880497:Free [Qualitative Concept]
   760   C1882327:%{Predicted} [Quantitative Concept]
   760   C1996904:Free [Qualitative Concept]

Phrase: "with structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "determined by phylogenetic comparison."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Comparison [Activity]
Processing 00000000.tx.261: Nucleic Acids Res 19:27072714[Abstract] Mathews DH, Sabina J, Zuker M, Turner DH 1999 Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. 

Phrase: "Nucleic Acids Res 19"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0001128:Acids [Chemical]
   812   C0007610:Nucleic [Cell Component]
   812   C2347379:RES [Finding]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: ":"

Phrase: "27072714"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Mathews DH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1832586:DH [Disease or Syndrome]

Phrase: "Sabina J,"

Phrase: "Zuker M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Turner DH 1999 Expanded sequence dependence of thermodynamic parameters"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0011546:Dependence [Mental Process]
   742   C0439857:Dependence [Mental or Behavioral Dysfunction]
   742   C2698668:DEPENDENCE [Regulation or Law]

Phrase: "improves"

Phrase: "prediction of RNA secondary structure."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0681842:Prediction [Idea or Concept]
Processing 00000000.tx.262: J Mol Biol 288:911940[CrossRef][Medline] Minn AH, Patterson NB, Pack S, Hoffmann SC, Gavrilova O, Vinson C, Harlan DM, Shalev A 2003 Resistin is expressed in pancreatic islets. 

Phrase: "J Mol Biol 288"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C2346604:J/mol [Quantitative Concept]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "911940"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Minn AH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1836672:AH [Disease or Syndrome]

Phrase: "Patterson NB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0919442:NB [Gene or Genome]
   861   C1705347:NB [Gene or Genome]

Phrase: "Pack S,"

Phrase: "Hoffmann SC,"

Phrase: "Gavrilova O,"

Phrase: "Vinson C,"

Phrase: "Harlan DM,"

Phrase: "Shalev"

Phrase: "A 2003 Resistin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0963992:resistin [Amino Acid, Peptide, or Protein,Hormone]
   861   C1426906:RESISTIN [Gene or Genome]

Phrase: "is"

Phrase: "expressed in pancreatic islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   770   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
Processing 00000000.tx.263: Biochem Biophys Res Commun 310:641645[CrossRef][Medline]

Phrase: "Biochem Biophys Res Commun 310"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "641645"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

